Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,sterol binding (GO:0032934),0.658398034932274,1.9344418912557322,0.0,0.2798858435194658,0.218,5/56,0.67%,PTCH1;RORA;APOD;CAV1;VDAC2
prerank,G protein-coupled receptor binding (GO:0001664),0.5909252325832488,1.916600109653728,0.0,0.19478541812503367,0.288,11/132,5.01%,PTCH1;GNA14;ITGB4;PTCH2;HOMER2;WNT10A;WNT2B;WNT16;GNAQ;WNT5A;UTS2B
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.7592797873406856,-1.8421758085418272,0.0,0.5201720145550778,0.349,5/12,3.54%,IGF1;INSR;GNAS;PIK3R1;IGF2
prerank,death receptor binding (GO:0005123),0.7933116186353177,1.8238627062485904,0.006359300476947536,0.5017773230664297,0.703,2/15,0.24%,NGF;EDA
prerank,cholesterol binding (GO:0015485),0.6427347582635503,1.816575588904136,0.0027434842249657062,0.4061181411878736,0.729,8/47,8.05%,PTCH1;APOD;CAV1;VDAC2;GRAMD1B;OSBPL6;SOAT1;ABCA1
prerank,gap junction channel activity (GO:0005243),-0.5908954879160708,-1.8074873656816368,0.002770083102493075,0.38568309626199143,0.459,4/22,2.67%,GJB6;GJC1;GJD3;GJA1
prerank,wide pore channel activity (GO:0022829),-0.5832207660406652,-1.8023022827078512,0.0056022408963585435,0.27564670856764806,0.483,4/23,2.67%,GJB6;GJC1;GJD3;GJA1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.7401375165066952,-1.8015331024502488,0.0045045045045045045,0.20756864042342046,0.485,4/10,7.99%,SLCO3A1;SLCO1C1;SLC22A6;SLCO2A1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6881244075135843,-1.7898265281952968,0.009925558312655087,0.1873953026794575,0.523,4/13,1.23%,PDGFD;IL1R1;PDGFRB;PDGFRA
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6540355261628518,1.767833742836365,0.007072135785007072,0.5684708416348069,0.902,10/35,8.30%,PKDCC;TEC;ITK;CLK1;TXK;PEAK1;SRC;FER;ABL2;DYRK1A
prerank,receptor antagonist activity (GO:0048019),0.7373026796264741,1.7189268693959348,0.011023622047244094,0.7966345377201013,0.985,2/17,1.01%,PXDN;DKKL1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7117605148333248,-1.7029639794628801,0.00954653937947494,0.37808799206086674,0.828,4/11,15.75%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7169643093083415,-1.6977426541800733,0.013333333333333334,0.3386834270592127,0.841,5/10,13.33%,SHANK3;GNAS;SQSTM1;IGSF11;SHANK2
prerank,insulin-like growth factor binding (GO:0005520),0.723312005866299,1.674711492980324,0.018487394957983194,1.0,0.998,3/15,0.35%,ITGB4;ITGA6;IGFBP6
prerank,insulin-like growth factor I binding (GO:0031994),0.7441298942212997,1.663267352139773,0.012237762237762238,0.9780639168596199,0.999,3/13,0.35%,ITGB4;ITGA6;IGFBP6
prerank,neuropeptide receptor activity (GO:0008188),0.6190051093986251,1.6340920107353516,0.035982008995502246,1.0,0.999,3/29,2.84%,SORCS2;SSTR1;KISS1R
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7310869550054909,1.6153202024406328,0.033003300330033,1.0,0.999,2/14,2.53%,RDH10;RDH5
prerank,O-acyltransferase activity (GO:0008374),0.6007484928125962,1.6128331233584952,0.03115727002967359,1.0,0.999,6/30,7.00%,MBOAT2;MOGAT2;MOGAT3;GPAT3;AWAT2;SOAT1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.5732203928980225,-1.6068455727534534,0.015625,0.6499371485279524,0.983,6/18,2.94%,ENG;SMAD3;SMAD6;TGFBR3;FKBP1A;TGFBR1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.5112638311242365,-1.5823202590267043,0.01744186046511628,0.6997375675377661,0.991,10/27,10.22%,SLC22A8;SLC26A7;ANO1;SLC39A8;SLC22A6;SLC26A2;SLC39A14;SLC25A30;SLC25A11;LRRC8A
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.734183797448338,1.564866072787906,0.03231597845601436,1.0,1.0,2/11,3.04%,ROR2;STK38
prerank,actinin binding (GO:0042805),0.6291077517229511,1.5644072219312655,0.04953560371517028,1.0,1.0,6/21,7.54%,MAGI1;KCNA5;PDLIM4;CSRP3;DAG1;RARA
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6811473968767608,1.5625944647880856,0.05709342560553633,1.0,1.0,7/14,17.69%,MINDY3;MINDY2;USP13;OTUD7B;MINDY4;USP15;USP9X
prerank,syntaxin binding (GO:0019905),-0.40721478671786976,-1.5590631285654415,0.004694835680751174,0.7529156467085677,0.995,22/61,20.75%,DAPK1;UNC13C;STXBP3;NAPA;TMED9;STX8;SYT9;GOLGA2;RAB11A;LRRK2;SYNPR;SYPL1;STXBP4;CPLX2;STX16;SCFD1;STX6;BLOC1S6;SNAP47;UNC13A;SNAP25;SYT6
prerank,lipoprotein particle receptor binding (GO:0070325),-0.49001419964674414,-1.553061409044392,0.027190332326283987,0.7134682585029922,0.997,8/27,13.51%,PICALM;LRP1;AP2A1;DNAJA1;APOE;LDLRAP1;ANKRA2;MESD
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5060569143708187,-1.5492175379822255,0.04335260115606936,0.6722593450215019,0.997,15/23,27.02%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;CNP;PDE4A;PDE1B;PDE4C;PDE4B;PDE6A;PDE3B;PDE7A
prerank,CoA-ligase activity (GO:0016405),-0.5920733404138617,-1.5470569255495625,0.04449648711943794,0.6308068907605792,0.997,5/14,21.33%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3961685536490925,-1.5468206382783531,0.004672897196261682,0.5867019517036057,0.997,23/72,9.50%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;ACTN2;MYO1B;MARK1;KCNJ2;GSDME;SNX21;COMMD1;SYT7;ANXA2;HIP1R;TWF1;FRMPD4;RPH3A;TULP3;LDLRAP1;CAPG;SLC9A1
prerank,GABA receptor binding (GO:0050811),-0.6179783920071626,-1.544692109758291,0.05938242280285035,0.5551465431690373,0.997,4/11,17.71%,ARFGEF2;GABARAPL1;GABARAP;LHFPL4
prerank,calcium-release channel activity (GO:0015278),0.6607747651441254,1.5418203007153979,0.06732348111658457,1.0,1.0,4/17,3.39%,ITPR2;ITPR3;TPCN1;FKBP1B
prerank,kinase activator activity (GO:0019209),-0.4717288360081685,-1.5406293573434535,0.011627906976744186,0.5363579225934502,0.997,12/30,25.45%,PRKAG2;MADD;GPRC5C;BCL10;RPLP1;CDK5R1;GPRC5B;WNT11;GPRC5A;NCKAP1L;WNK1;AGAP2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.491752076860344,-1.5398141861760704,0.03058103975535168,0.5078803681578486,0.997,9/26,12.56%,SLC16A12;SLC6A6;ABCG2;SLC5A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC6A1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6624899367076806,1.5331269378402854,0.06656101426307448,1.0,1.0,7/16,15.58%,MTMR7;MTMR6;MTMR3;INPP5F;PTEN;MTMR12;MTMR1
prerank,growth factor activity (GO:0008083),0.5049708322432584,1.531372411506682,0.0275,1.0,1.0,4/74,2.27%,NGF;FGF7;FGF1;JAG1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.5043282730789146,-1.524480089553334,0.03757225433526012,0.5311015547469401,0.998,9/22,21.42%,PICALM;AP2A1;DNAJA1;APOE;LDLRAP1;ANKRA2;MESD;CLU;APBB3
prerank,aminopeptidase activity (GO:0004177),0.5908691523338097,1.523489295307925,0.05105105105105105,1.0,1.0,11/26,15.00%,XPNPEP2;MMP15;RNPEP;LVRN;BLMH;LNPEP;XPNPEP3;MMP16;KDM8;LTA4H;MMP14
prerank,voltage-gated ion channel activity (GO:0005244),0.6894623452235539,1.5226975014220998,0.06446280991735537,1.0,1.0,3/14,4.85%,VDAC2;ANO6;CACNA1H
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.6137223603434858,1.5193084773940948,0.06045751633986928,1.0,1.0,14/20,29.96%,USP50;UFSP2;USP47;COPS5;USP9X;SENP2;SENP3;OTUB1;SENP5;OTULINL;SENP1;DESI2;EIF3H;OTUD5
prerank,protein tyrosine kinase activity (GO:0004713),0.476694649178005,1.5175175516455963,0.021003500583430573,1.0,1.0,18/108,6.50%,ROR2;PKDCC;ROR1;TEC;NTRK3;FGFR1;EGFR;MUSK;ITK;CLK1;WEE1;TXK;PEAK1;SRC;HIPK1;FER;EPHB2;ABL2
prerank,alpha-actinin binding (GO:0051393),0.5976081824575855,1.5075205441624633,0.06676783004552352,1.0,1.0,5/24,7.54%,MAGI1;KCNA5;PDLIM4;DAG1;RARA
prerank,I-SMAD binding (GO:0070411),-0.5719195120227203,-1.5073968337405006,0.05623471882640587,0.5639876734509115,0.999,5/13,4.23%,SMAD3;SMAD6;SMAD9;TGFBR1;SMAD5
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5988590012874377,-1.5054945174125738,0.059496567505720827,0.5424015878266623,0.999,5/12,20.10%,SLC6A6;SLC38A7;SLC3A2;SLC38A5;SLC1A4
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.41532446490711233,-1.505222375096773,0.008097165991902834,0.5173139265630169,0.999,19/47,23.69%,SLC7A11;SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC16A2;SLC6A1;SLC38A7;SLC3A2;SLC22A2;SLC38A5;SLC25A29;SLC38A1;SLC38A9;SLC7A10
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.5031510963011951,-1.4999574081158316,0.04857142857142857,0.5117348810633627,0.999,14/21,27.02%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;PDE4A;PDE1B;PDE4C;PDE4B;PDE6A;PDE3B;PDE7A
prerank,tropomyosin binding (GO:0005523),0.6479104991625648,1.4959996495116017,0.07258064516129033,1.0,1.0,6/16,8.80%,SMTNL1;TMOD2;SMTNL2;S100A6;TMOD1;CALD1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5965093220390465,-1.4891734356575177,0.053864168618266976,0.5251011808022552,0.999,8/12,25.77%,SDHB;XDH;AOX1;CIAPIN1;FXN;ISCA2;ISCU;CISD2
prerank,carbohydrate kinase activity (GO:0019200),0.6711422392487184,1.4799553112367434,0.07586206896551724,1.0,1.0,6/11,16.79%,HK2;GALK1;NAGK;GALK2;FGGY;POMK
prerank,metalloaminopeptidase activity (GO:0070006),0.6269797509878025,1.4763819518775685,0.08375209380234507,1.0,1.0,10/16,21.40%,MMP15;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;MMP14;XPNPEP1;ENPEP
prerank,transcription coactivator binding (GO:0001223),0.5975975262966419,1.4701538269283503,0.09682539682539683,1.0,1.0,3/20,4.20%,RORA;VGLL4;PGR
prerank,transcription corepressor binding (GO:0001222),0.573342507535505,1.4689493520444283,0.08189655172413793,1.0,1.0,1/27,0.03%,RORA
prerank,hexosaminidase activity (GO:0015929),0.6682858653734872,1.4675420064309732,0.09075342465753425,1.0,1.0,6/12,17.17%,NAGA;HEXA;CEMIP2;HEXB;OGA;CEMIP
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5271636710735179,1.466039780630962,0.05953991880920163,1.0,1.0,2/42,0.09%,STXBP6;NTNG1
prerank,transforming growth factor beta binding (GO:0050431),-0.47719990487122055,-1.464208720068676,0.05099150141643059,0.5920013231888852,0.999,7/23,8.37%,ENG;TGFBR3;TGFBR1;ACVRL1;NRROS;TGFB3;VASN
prerank,ATPase binding (GO:0051117),0.48505346071200006,1.462576394378397,0.05289672544080604,1.0,1.0,19/71,10.54%,CAV1;EGFR;SLC2A13;SLC26A9;NUFIP1;PDE4D;PGR;SRC;NCSTN;SELENOS;SNX10;RDX;ALDOB;ABCA1;ATP6V0A1;SNU13;ATP1B3;CHMP4A;ANK1
prerank,ephrin receptor binding (GO:0046875),0.6059192585696395,1.4618774135859545,0.0732484076433121,0.9968035490645318,1.0,8/21,16.75%,EFNA5;EFNB1;SRC;EFNB2;ANKS1B;ANKS1A;EFNA3;EFNB3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5845243279421329,-1.460751791823377,0.06264501160092807,0.5798806483625538,0.999,5/12,3.91%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5889248448647755,1.457018450341447,0.07230769230769231,0.9903857492865221,1.0,3/21,8.36%,FGF7;FGF1;FGF18
prerank,mechanosensitive ion channel activity (GO:0008381),0.6742446889775445,1.4557870745697146,0.09385113268608414,0.9671362485987439,1.0,5/12,14.27%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6461895006016504,1.4549548619443617,0.09492635024549918,0.9432520026480248,1.0,6/14,15.58%,MTMR7;MTMR6;MTMR3;PTEN;MTMR12;MTMR1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.6139655781034593,1.4524848620403754,0.10147299509001637,0.9292155972830142,1.0,6/15,10.84%,PHLDA3;SESTD1;LANCL2;SH3PXD2B;OBSCN;SAP30L
prerank,peptidase activator activity (GO:0016504),0.5866208355287195,1.446890348967943,0.107981220657277,0.9300373341948918,1.0,5/22,8.56%,CAV1;APH1B;PSME3;NLRC4;EBAG9
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.35350531373546557,-1.4455194788162897,0.021505376344086023,0.6097315453319423,0.999,25/91,9.50%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;ACTN2;MYO1B;MARK1;KCNJ2;GSDME;SNX21;COMMD1;SYT7;ANXA2;HIP1R;KCNH1;TWF1;FRMPD4;RPH3A;TULP3;WIPI1;LDLRAP1;CAPG;SLC9A1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5176922066683901,-1.4440674365485788,0.08311688311688312,0.592541625317014,0.999,5/18,3.91%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,protein kinase activator activity (GO:0030295),-0.37772759659397354,-1.4419522649034298,0.023076923076923078,0.5793582533906715,0.999,27/60,29.04%,PRKAG2;FAM20A;AFAP1L2;IGF2;MADD;GPRC5C;CALM1;MAP2K2;RPLP1;ABI1;RICTOR;CDK5R1;CALM3;GPRC5B;WNT11;CD24;GPRC5A;NCKAP1L;ERBB3;MAP2K1;WNK1;AGAP2;MLST8;PARP16;TPX2;DDX3X;GRM5
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6081976827645783,1.436362217068936,0.10679611650485436,0.9583381238111732,1.0,1/18,0.06%,STXBP6
prerank,peptide hormone receptor binding (GO:0051428),0.6693680535012294,1.4256393288200362,0.105,0.989230237296974,1.0,2/11,3.90%,GNRH1;PTHLH
prerank,histone acetyltransferase binding (GO:0035035),-0.4814410332178456,-1.419314823982731,0.07387862796833773,0.6395984806141423,1.0,5/21,9.88%,GLI3;HIF1A;MEF2A;CITED2;EPAS1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5754357563842627,-1.41926565063292,0.08585858585858586,0.6184637777042673,1.0,8/11,29.80%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4;PYCARD;CASP1
prerank,retinoic acid binding (GO:0001972),0.6414242748572971,1.4192522157666119,0.10884353741496598,0.9956022417085365,1.0,2/12,7.54%,NR2F2;RARA
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.48032306499151095,1.417403123182217,0.07289002557544758,0.9798841204027784,1.0,8/60,2.19%,ROR2;ROR1;NTRK3;FGFR1;EFEMP1;EGFR;MUSK;NRP2
prerank,syntaxin-1 binding (GO:0017075),-0.4700170123764651,-1.4125224087244732,0.07492795389048991,0.6217109685956058,1.0,9/22,20.73%,DAPK1;UNC13C;STXBP3;LRRK2;SYNPR;SYPL1;CPLX2;UNC13A;SNAP25
prerank,NADP binding (GO:0050661),-0.425520384853532,-1.4103966886657529,0.06622516556291391,0.610444922262653,1.0,14/32,20.05%,DPYD;NOS3;CRYZL1;CAT;NOX1;QDPR;ME1;DHFR;MTRR;PGD;NOS1;DHCR7;ME3;CRYZ
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5325028261130829,-1.4073967135603265,0.08241758241758242,0.6032634649505307,1.0,7/14,23.72%,SDHB;NFU1;CIAO3;ISCA2;RSAD2;ISCU;EXO5
prerank,amyloid-beta binding (GO:0001540),-0.3544650402952245,-1.4032016798419482,0.015957446808510637,0.598563950886342,1.0,17/79,13.01%,PICALM;INSR;ITM2A;COL25A1;FZD6;LRP1;EPHA4;GRIA2;LDLR;GRIN2B;APBB2;APOE;LDLRAP1;GRIN1;VBP1;CRYAB;TGFB2
prerank,Wnt-activated receptor activity (GO:0042813),0.6022528578075877,1.4007388035372035,0.12619808306709265,1.0,1.0,6/15,14.48%,ROR1;FZD2;PKD1;FZD7;FZD9;FZD3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5910058062124466,1.3989910463094273,0.11323763955342903,1.0,1.0,2/18,2.53%,HSD17B3;RDH5
prerank,gated channel activity (GO:0022836),0.6385245558524342,1.395220352802378,0.12274959083469722,1.0,1.0,6/14,14.77%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A;TMEM266
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5928034415155221,-1.3937395204864296,0.1,0.6131233873635461,1.0,4/10,11.07%,NOX4;CYBA;NOX1;NCF2
prerank,voltage-gated anion channel activity (GO:0008308),0.6296590860377499,1.3917528623819753,0.12040133779264214,1.0,1.0,4/15,6.20%,VDAC2;ANO6;CLCN2;CLCN1
prerank,pyrophosphatase activity (GO:0016462),-0.37669995067159084,-1.3914919104696037,0.030927835051546393,0.6036255375454846,1.0,33/50,40.45%,ENPP1;ENTPD1;ENPP3;ALPL;PLPP1;NUDT3;LHPP;ENTPD5;TRPM2;PPA1;PLPP4;NUDT11;ENTPD3;DHX29;CILP;FITM2;DCP2;NUDT16;NUDT16L1;CILP2;NUDT22;DDX3X;BNIPL;PRUNE1;ENTPD6;NUDT10;ATCAY;RNGTT;DCTPP1;PRUNE2;PLPP5;NUDT14;NUDT9
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5036440131496628,1.3900808641125855,0.10848400556328233,1.0,1.0,12/38,12.95%,SORBS1;RGS14;AXIN1;CD3G;NUP62;CARD10;TRADD;NCK2;GAB2;LAT;SPAG9;SH2B1
prerank,retinoid binding (GO:0005501),-0.4690414520721137,-1.386228220009932,0.11538461538461539,0.6045542730954574,1.0,6/22,9.35%,ALDH1A2;RBP1;CYP26B1;RBP4;ABCA4;PTGDS
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.392127339647137,1.3848104346327543,0.002002002002002002,1.0,1.0,86/731,8.42%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;ZSCAN25;PBX1;BHLHE22;ZBTB20;NEUROD6;RUNX2;GLI2;NFIA;HIVEP2;ZSCAN18;HOXB6;TEF;ZKSCAN7;CIART;SPI1;KLF3;ZNF418;FOXK1;FOXO3;FOXP4;NPAS2;SOX9;PGR;REL;CREB3L1;GLIS2;ZNF585B;ZNF585A;CHD2;KLF10;HDAC4;SATB1;ZBTB3;POU5F2;HEYL;BHLHE40;SP3;ZNF697;NRIP1;ZFP1;TEAD3;ONECUT1;ZFP14;CTCF;TBX2;NRF1;NFE2L1;HIC1;ZFP62;ZNF431;PAX3;HOXC10;ONECUT3;RREB1;MAFG;RARA;PKNOX2;USF2;FOXK2;E4F1;MYPOP;ZNF628;TBX18
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5632803569423217,1.3813543572307196,0.11248073959938366,1.0,1.0,5/21,18.62%,CHRNB3;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3906865094433418,1.377212088650378,0.0010030090270812437,1.0,1.0,86/732,8.42%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;ZSCAN25;PBX1;BHLHE22;ZBTB20;NEUROD6;RUNX2;GLI2;NFIA;HIVEP2;ZSCAN18;HOXB6;TEF;ZKSCAN7;CIART;SPI1;KLF3;ZNF418;FOXK1;FOXO3;FOXP4;NPAS2;SOX9;PGR;REL;GLIS2;ZNF585B;ZNF585A;CHD2;KLF10;HDAC4;SATB1;ZBTB3;POU5F2;HEYL;BHLHE40;SP3;ZNF697;NRIP1;ZFP1;TEAD3;ONECUT1;ZFP14;CTCF;TBX2;NRF1;NFE2L1;HIC1;ZFP62;ZNF431;PAX3;HOXC10;ONECUT3;RREB1;MAFG;RARA;PKNOX2;USF2;FOXK2;E4F1;ISL1;MYPOP;ZNF628;TBX18
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5649943288043108,-1.3764598403983779,0.12217194570135746,0.6207608336089977,1.0,2/10,1.71%,PRKAG2;PKIG
prerank,tau protein binding (GO:0048156),-0.39341930929498314,-1.3750289402549671,0.04477611940298507,0.6092613043588896,1.0,10/40,12.20%,PICALM;ROCK2;MARK1;EP300;APOE;ACTB;LGMN;GSK3A;TTBK1;TAOK2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6480430601172176,1.374827785620828,0.13848920863309352,0.9942276909686927,1.0,4/10,15.25%,DPYS;CAD;DPYSL2;DPYSL5
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.4567736769220439,-1.3738879679205784,0.08877284595300261,0.5978921601058552,1.0,10/21,30.20%,ARFGEF2;WASF3;AKAP6;AKAP1;PJA2;AKAP8L;AKAP7;ACBD3;KCNQ1;RYR2
prerank,androgen receptor binding (GO:0050681),-0.44643176506773347,-1.3735966277519733,0.08734939759036145,0.5843395754500051,1.0,8/25,18.60%,FOXP1;EP300;RNF6;WIPI1;SNW1;KDM1A;ARID5A;PRPF6
prerank,clathrin adaptor activity (GO:0035615),-0.5137700818582434,-1.3720159649858676,0.08516483516483517,0.5751902084022494,1.0,5/15,8.38%,HIP1;DAB2;AP2A1;HIP1R;LDLRAP1
prerank,beta-tubulin binding (GO:0048487),0.5220484013826325,1.3652176920605226,0.13549337260677466,1.0,1.0,9/31,13.89%,DLEC1;TRPV4;RACGAP1;SMC3;SPAST;IFT74;ARL8B;EMD;HTT
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6420600142076952,1.3619988619436914,0.141396933560477,1.0,1.0,3/10,8.17%,EHHADH;HADHB;HSD17B4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6342634789428644,1.3608905576438903,0.1705150976909414,1.0,1.0,1/10,0.29%,CXADR
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6019049384182016,1.3608741448440453,0.14355628058727568,0.9833470119266904,1.0,1/13,0.68%,EHHADH
prerank,alpha-tubulin binding (GO:0043014),0.5258777830341561,1.3589439322279204,0.10968660968660969,0.9734893312352793,1.0,11/31,18.44%,DLEC1;TRPV4;RACGAP1;SPAST;FNTA;HDAC6;INO80;ARL8B;TBCE;SETD2;OFD1
prerank,acetylcholine receptor activity (GO:0015464),0.5370512303297456,1.3518410487177372,0.14074074074074075,0.9884715269653075,1.0,5/22,18.62%,CHRNB3;CHRM2;CHRM3;CHRNA7;CHRFAM7A
prerank,LRR domain binding (GO:0030275),-0.5134168254444342,-1.3517758664936799,0.11192214111922141,0.6255815492080099,1.0,7/14,19.23%,ROBO1;PAWR;LRRFIP2;ZXDC;POLR2J;ATF4;DAPK3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5291501334006903,-1.3494656617532266,0.1377672209026128,0.6186136589179924,1.0,10/12,27.02%,PDE7B;PDE8A;PDE8B;PDE2A;PDE4A;PDE1B;PDE4C;PDE4B;PDE3B;PDE7A
prerank,death receptor activity (GO:0005035),-0.5600973239577363,-1.3492007848239307,0.125,0.605508876392105,1.0,4/11,13.22%,TNFRSF19;FAS;TNFRSF1B;TNFRSF11A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5698927438546183,1.3455378668509383,0.1498371335504886,1.0,1.0,2/15,1.73%,ALDH1A3;ALDH9A1
prerank,phosphatase binding (GO:0019902),0.42371712980895015,1.3440421447253776,0.0885478158205431,0.9897196062149342,1.0,27/105,16.55%,NFATC2;PXN;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;SPRED1;EIF2AK3;SFI1;PIK3R2;MAP3K5;ELL;MTMR3;ANAPC5;ANAPC7;DLG3;PTPRT;ANK1;TRPC4AP;MVP;ANAPC4;AP3B1;BAD;ERBB2;TBK1;JAK1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5652176991329767,-1.3439038474823015,0.1295843520782396,0.6104917372607114,1.0,6/10,22.70%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4
prerank,endopeptidase inhibitor activity (GO:0004866),0.4368711104651639,1.34388316703009,0.09079754601226994,0.9733075856127184,1.0,4/82,1.46%,NGF;SPINK1;SERPINB2;SERPING1
prerank,serine-type endopeptidase activity (GO:0004252),0.44058150460817475,1.340802310315419,0.09681372549019608,0.9705455106330354,1.0,16/80,17.70%,CORIN;CTRC;FAP;KLK2;PCSK5;CD5L;DPP4;PCSK7;CELA1;PROC;HTRA2;PLG;TYSND1;MBTPS1;MASP2;RHBDF1
prerank,GTPase inhibitor activity (GO:0005095),-0.5269079214391972,-1.3401427866515736,0.13902439024390245,0.6091612530880273,1.0,7/13,19.33%,SLIT2;TNK2;CPEB2;IQGAP2;RHOH;ARL2;GPS1
prerank,telomerase RNA binding (GO:0070034),0.5409232193069791,1.338730110357174,0.13803680981595093,0.9634156121551523,1.0,6/22,12.66%,HNRNPC;NAF1;WRAP53;EXOSC10;SMG7;TEP1
prerank,peptidase inhibitor activity (GO:0030414),0.4990271677692644,1.3368148928552475,0.12408759124087591,0.9558064353818001,1.0,2/33,0.61%,GPC3;SPINK1
prerank,receptor ligand activity (GO:0048018),0.3962187097327794,1.3359317947600229,0.041401273885350316,0.9440809378479453,1.0,28/245,10.39%,NGF;EDA;FGF7;INHBB;IL19;WNT10A;FGF1;JAG1;SEMA4B;WNT2B;INSL6;GNRH1;IL1A;WNT16;PTHLH;NBL1;BMP5;WNT5A;APLN;BMP15;ARTN;SEMA3A;DPP4;FGF18;TAFA5;HMGB1;LEFTY1;C1QTNF12
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3533040852768945,-1.3299022927019843,0.07142857142857142,0.6277307310618592,1.0,13/55,13.14%,SLC16A12;SLC13A3;SLC6A6;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC38A7
prerank,antiporter activity (GO:0015297),0.5446337027149567,1.3283823605861904,0.1619496855345912,0.9607642911417614,1.0,4/20,7.73%,SLC35A1;SLC35D3;SLC35C2;SLC35D2
prerank,solute:proton symporter activity (GO:0015295),-0.4945125344470282,-1.327316539904424,0.13793103448275862,0.622178535986012,1.0,8/16,10.07%,SLC39A8;SLC17A5;SLC15A2;SLC11A2;SLC15A4;SLC33A1;SLC2A10;CTNS
prerank,mannose binding (GO:0005537),0.6225947817182329,1.3267880957234268,0.1692047377326565,0.9526224355177427,1.0,2/12,3.65%,COLEC11;LMAN2
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.3558060639366109,-1.3248588417458036,0.06439393939393939,0.6164260668210387,1.0,9/49,7.85%,ANXA3;C2CD5;DYSF;SYT9;SYT7;ANXA2;RPH3A;MCTP2;ANXA1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6098372218141601,1.3246689453457337,0.1759581881533101,0.9471895552619263,1.0,2/11,5.44%,ARG1;DDAH2
prerank,protein phosphatase 1 binding (GO:0008157),0.5435354114787808,1.3233142217905682,0.16506410256410256,0.9388410734886423,1.0,4/21,6.14%,SMTNL1;SH3RF2;SMTNL2;AKAP11
prerank,SH2 domain binding (GO:0042169),0.4918918072304314,1.3215225177004946,0.15749235474006115,0.9327034848909833,1.0,6/31,7.15%,DLC1;TRPV4;SRC;NUP62;SH3PXD2B;DAG1
prerank,sequence-specific DNA binding (GO:0043565),0.375271639591355,1.3210562091235096,0.009045226130653266,0.9209896201224551,1.0,83/590,12.35%,RORA;MEOX2;KLF5;ETV4;NFATC2;ETV1;PPARGC1A;PAX9;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;MYBBP1A;RUNX2;ETV5;GLI2;HOXB6;TEF;KMT2A;KLF3;HLX;FOXK1;FOXO3;NPAS2;SOX9;CREB3L1;GLIS2;KLF10;HDAC4;SATB1;BHLHE40;SP3;ZFP1;ONECUT1;STN1;SIRT3;CTCF;TBX2;HIC1;PAX3;HOXC10;ONECUT3;MAFG;RARA;PKNOX2;USF2;LHX6;FOXK2;ISL1;TBX18;UPF2;LIN28B;SLTM;TET1;MECP2;RORB;POU4F1;HDAC2;DBP;TLX3;TFEB;FBXL19;MMP12;RARG;LONP1;EN2;EGR1;ZBTB49;ZNF148;ERF;NFE2L2;SMG7
prerank,alkali metal ion binding (GO:0031420),0.5779688407223043,1.3084646024730926,0.18354430379746836,0.9590447940102965,1.0,4/13,7.68%,TDG;HDAC4;ATP1A2;ACAT1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.45756542540746864,1.3072376220907749,0.13161465400271372,0.9503691315953444,1.0,8/48,7.83%,PIEZO2;NALCN;TRPM3;SLC12A2;TRPV4;SLC12A4;SLC4A11;PIEZO1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.37849962852119,-1.3066139310835074,0.08333333333333333,0.663879667646086,1.0,7/37,7.99%,SLC22A8;SLCO3A1;SLCO1C1;SLC22A6;SLC22A4;COX6B1;SLCO2A1
prerank,phosphatase activator activity (GO:0019211),-0.5029151353906536,-1.3055379918950603,0.1475,0.6541906918751114,1.0,9/14,32.59%,FRS2;CALM1;BMP2;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5390914743179355,1.304497614564548,0.1568627450980392,0.9487432245186157,1.0,4/20,3.64%,MPP1;CASK;MAGI3;TJP2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3692250419515852,1.3025832389531096,0.00501002004008016,0.94361663046925,1.0,91/831,8.42%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;ZSCAN25;PBX1;BHLHE22;ZBTB20;NPAS3;NEUROD6;RUNX2;ETV5;GLI2;NFIA;HIVEP2;ZSCAN18;HOXB6;TEF;ZKSCAN7;CIART;SPI1;KLF3;ZNF418;FOXK1;FOXO3;FOXP4;NPAS2;SOX9;ZBTB8A;PGR;REL;GLIS2;ZNF585B;ZNF585A;CHD2;KLF10;HDAC4;SATB1;ZBTB3;POU5F2;HEYL;BHLHE40;ZFP3;SP3;ZNF697;NRIP1;ZFP1;ZFP90;TEAD3;ONECUT1;ZFP14;CTCF;TBX2;NRF1;NFE2L1;HIC1;ZFP62;ZNF431;PAX3;HOXC10;ONECUT3;RREB1;MAFG;RARA;PKNOX2;USF2;LHX6;FOXK2;E4F1;MYPOP;ZNF628;TBX18
prerank,acid-thiol ligase activity (GO:0016878),-0.5183129272557444,-1.3015194038926179,0.14454976303317535,0.6544931624838501,1.0,5/13,21.33%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,channel activity (GO:0015267),0.46284331244167315,1.3007585562653308,0.16260162601626016,0.9379828470224972,1.0,9/41,18.91%,CHRNB3;TRPV4;MPV17;PANX2;AQP1;TRPV2;TMEM266;CHRNA7;BAX
prerank,NAD binding (GO:0051287),-0.4172134190226547,-1.2990084167489286,0.12569832402234637,0.6512853309809976,1.0,10/26,21.56%,ALDH1A1;CRYL1;BDH2;QDPR;ZC3HAV1;ME1;HADH;CRYZ;SORD;ALDH2
prerank,protein phosphatase binding (GO:0019903),0.4056011680836829,1.2983103482321,0.10023310023310024,0.9352868974731018,1.0,32/117,16.55%,PXN;SMTNL1;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;EIF2AK3;SMTNL2;ATP2B4;AKAP11;PIK3R2;MAP3K5;BOD1L1;MTMR3;ANAPC5;ANAPC7;MASTL;PTPRT;STRN;ANK1;MVP;SMG7;ENSA;PTPA;ANAPC4;AP3B1;BAD;ADCY8;ERBB2;TBK1;JAK1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4912637975959981,-1.2966730450764474,0.16793893129770993,0.6463955733317295,1.0,6/14,25.24%,NOX4;CYBA;NOX1;NCF2;AIFM1;KMO
prerank,BMP binding (GO:0036122),-0.5133034058722274,-1.2956292058469476,0.16820276497695852,0.6381673833939796,1.0,3/11,6.95%,ENG;BMPR2;GREM2
prerank,cGMP binding (GO:0030553),-0.5338134216387722,-1.291250454045511,0.17772511848341233,0.6411086930027682,1.0,4/11,9.13%,RAPGEF2;PDE5A;PDE10A;PDE2A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5722532594268958,1.282428947862757,0.2113676731793961,0.9890938775510204,1.0,8/13,24.42%,TARBP1;WDR4;FTSJ1;TRMT5;THUMPD3;TRMT1L;TRMT1;THUMPD2
prerank,myosin II binding (GO:0045159),-0.5435548230188276,-1.2820994616991588,0.15839243498817968,0.6579187151379653,1.0,5/10,27.29%,TRIOBP;LLGL2;MYL4;SHROOM1;STXBP5
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4359461329591453,1.2804991242268948,0.15645371577574968,0.983942564666472,1.0,6/60,1.86%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK
prerank,cytokine receptor activity (GO:0004896),-0.3182184492214662,-1.2744802070503671,0.07909604519774012,0.6708621472664376,1.0,14/83,8.70%,IL1R1;IL31RA;OSMR;GHR;IL13RA1;IL6R;IFNAR2;IL1RAP;IL10RB;F3;LIFR;CNTFR;IL15RA;CMKLR1
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3998078091443703,-1.2725383169149078,0.13496932515337423,0.6662573602381741,1.0,11/27,22.32%,MED21;POLR3B;TENT2;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F
prerank,endopeptidase activator activity (GO:0061133),0.5983553513539714,1.2700209050684328,0.2099644128113879,1.0,1.0,3/10,7.19%,APH1B;PSME3;NLRC4
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5249506006913326,1.2687695282998113,0.22682119205298013,1.0,1.0,1/19,0.26%,EFNA5
prerank,Tat protein binding (GO:0030957),0.5842940667171431,1.2685098008753226,0.21392190152801357,0.996656444749504,1.0,1/10,0.31%,MDFIC
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4176725340660788,1.2680204279929999,0.15151515151515152,0.9862666523073609,1.0,22/71,14.93%,UBASH3B;PTPN13;PTPRF;EYA1;PTPDC1;PTPN14;TPTE;PTPN22;PTPRC;PTP4A2;PTPRJ;MTMR6;MTMR3;PTPRT;HACD2;PTPN18;PTEN;PTPRA;PALD1;PTPN6;PTPRU;PTPRO
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5613854045683528,1.2661223572558296,0.21440536013400335,0.9822270086574647,1.0,1/14,0.04%,NGF
prerank,serine-type peptidase activity (GO:0008236),0.406105026245143,1.2655962135943184,0.1410105757931845,0.9725202814248809,1.0,23/96,21.63%,CORIN;CTRC;FAP;KLK2;NAALAD2;PCSK5;CD5L;DPP4;PCSK7;CELA1;PROC;HTRA2;PLG;TYSND1;MBTPS1;MASP2;RHBDF1;TMPRSS7;GZMK;PLAT;HGF;RHBDL3;PRSS8
prerank,sialyltransferase activity (GO:0008373),-0.43185299343893024,-1.264490604489029,0.14627659574468085,0.6801702792253922,1.0,6/20,5.44%,ST3GAL6;ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3;ST6GALNAC2
prerank,vinculin binding (GO:0017166),0.5750845420061751,1.2631034783471753,0.2113676731793961,0.9710220560233503,1.0,3/11,7.15%,UTRN;PXN;DAG1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5033789535588772,1.2623361561211506,0.2071097372488408,0.9625465972291668,1.0,6/20,11.07%,MOGAT2;MOGAT3;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,diacylglycerol kinase activity (GO:0004143),0.5743245507370524,1.2538508010090075,0.22434782608695653,0.9848510929437738,1.0,2/11,3.64%,DGKA;DGKZ
prerank,transaminase activity (GO:0008483),0.5756139248699023,1.2526658937157675,0.22142857142857142,0.9777643061888189,1.0,4/11,13.35%,AADAT;ABAT;BCAT2;GOT1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5278881828999711,-1.2519514917683898,0.20512820512820512,0.7065777426824454,1.0,3/10,6.77%,MECOM;SETD5;PRDM16
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5549072037777798,1.2464827340920708,0.2167235494880546,0.9915558122075143,1.0,2/13,1.73%,ALDH1A3;ALDH9A1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.45832264874100875,-1.2452146006642835,0.17766497461928935,0.705563182269269,1.0,7/17,17.75%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,ephrin receptor activity (GO:0005003),-0.45832264874100875,-1.2452146006642835,0.17766497461928935,0.705563182269269,1.0,7/17,17.75%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4802791827509453,1.2450423874165422,0.20588235294117646,0.9861334142676019,1.0,6/25,11.77%,POR;FMO4;FMO2;FMO1;MICAL3;MSMO1
prerank,phosphate ion binding (GO:0042301),-0.5178544062357122,-1.2448681094452199,0.20763723150357996,0.6958027430723428,1.0,2/10,9.13%,RPH3A;PDE2A
prerank,transcription coregulator binding (GO:0001221),0.43766020876975475,1.2439457839027273,0.1836461126005362,0.9792923484059658,1.0,8/50,11.76%,RORA;VGLL4;UBE2I;PGR;CTCF;CHD6;HDAC6;ZBTB49
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5847496305449931,1.2392092434116917,0.23369565217391305,0.9871124034486266,1.0,3/11,13.15%,CNGB1;CNGA4;AQP1
prerank,cell adhesion mediator activity (GO:0098631),0.49222442519849835,1.2355548199362807,0.2140625,0.9912796804186607,1.0,2/24,4.46%,NTNG1;DSCAM
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.39028850538078,-1.2350743920921965,0.1751592356687898,0.7155059693862208,1.0,11/30,20.09%,SLC30A10;SLC39A10;SLC39A8;ATP7A;SLC31A1;SLC11A2;SLC39A14;SLC40A1;SLC30A4;TTYH1;SLC39A11
prerank,AMP binding (GO:0016208),-0.5025760430637268,-1.233554276342402,0.20417633410672853,0.709272690467609,1.0,2/11,2.05%,PRKAG2;MPPED2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.4898516155626501,1.2327386337805128,0.21396054628224584,0.9924066274439108,1.0,9/27,13.15%,ITPR2;SLC12A2;SLC12A3;ATP2B4;CNNM2;MRS2;TUSC3;ZDHHC13;AQP1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5650273078129424,1.2325919513127752,0.23518850987432674,0.9824167985348876,1.0,3/11,8.15%,EGFR;MAP3K1;MAP3K5
prerank,serotonin receptor activity (GO:0099589),0.4873311640315803,1.2299081672909287,0.2304075235109718,0.9621272862707088,1.0,1/22,0.33%,HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.4873311640315803,1.2299081672909287,0.2304075235109718,0.9621272862707088,1.0,1/22,0.33%,HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.4873311640315803,1.2299081672909287,0.2304075235109718,0.9621272862707088,1.0,1/22,0.33%,HRH1
prerank,exopeptidase activity (GO:0008238),0.43161689149439014,1.2245475236773204,0.20596205962059622,0.9730790107844678,1.0,13/50,12.71%,XPNPEP2;FAP;NAALAD2;CPE;CPA2;RNPEP;DPP4;BLMH;LNPEP;XPNPEP3;MME;KDM8;LTA4H
prerank,platelet-derived growth factor binding (GO:0048407),-0.5081545591017502,-1.2226134805181559,0.21852731591448932,0.7315654492031679,1.0,3/11,2.15%,PDGFRB;PDGFRA;COL5A1
prerank,double-stranded DNA binding (GO:0003690),0.3491558936042979,1.220241656551645,0.05443548387096774,0.9798899095473632,1.0,65/531,11.67%,MEOX2;KLF5;ETV4;NFATC2;ETV1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;EGFR;ZBTB20;RUNX2;ETV5;MSH6;TDG;GLI2;HOXB6;TEF;KLF3;FOXK1;FOXO3;NPAS2;SOX9;CREB3L1;GLIS2;KLF10;SATB1;NTHL1;BHLHE40;SP3;ZFP1;ONECUT1;TBX2;HIC1;PAX3;HOXC10;ONECUT3;MAFG;RARA;PKNOX2;MSH2;USF2;LHX6;ISL1;TBX18;LIN28B;MECP2;HMGB1;RORB;POU4F1;DBP;TLX3;TFEB;RARG;EN2;TDP1;EGR1;TOP1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3317980787839972,-1.2196039494865156,0.14741035856573706,0.7301770484258366,1.0,13/51,12.92%,SLC22A8;SLCO3A1;SLCO1C1;SLC7A5;SLC22A6;SLC22A4;SLC5A6;SLCO2A1;SLC25A30;SLC25A11;SLC16A2;TMEM241;MFSD2A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.44664301457202615,-1.218273707588717,0.23317307692307693,0.713757157566637,1.0,4/16,3.14%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.44664301457202615,-1.218273707588717,0.23317307692307693,0.713757157566637,1.0,4/16,3.14%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.39828922460631966,-1.2171119446690062,0.218562874251497,0.7069776160546919,1.0,7/24,13.30%,DAPK1;MKNK2;CAMK2A;CAMK4;MKNK1;MAPKAPK2;MAPKAPK3
prerank,store-operated calcium channel activity (GO:0015279),-0.5123397338239286,-1.216646229098374,0.24271844660194175,0.6987546617485125,1.0,5/10,19.35%,TRPC3;TRPC1;ORAI1;TRPC7;STIM2
prerank,cadherin binding (GO:0045296),0.35106852767294544,1.214416332453487,0.10880829015544041,0.992284331658625,1.0,97/315,21.03%,STXBP6;AHNAK;ITGA6;DOCK9;FMNL2;CDH13;F11R;PARVA;ARHGAP18;CDH11;PLCB3;EGFR;CDH5;CAPZB;CDH17;STK38;PFKP;CDH9;GIGYF2;TJP2;ADD1;EXOC3;SRC;ATIC;LRRC59;ZC3H15;USP8;PACSIN2;RDX;BAG3;CKAP5;CDH2;PTPRJ;CALD1;CHMP5;STK24;SFN;FLNB;PKP4;CGN;IST1;PTPRT;DIAPH3;CHMP4B;TBC1D2;SH3GLB2;COBLL1;APC;SNX2;NOP56;CEMIP2;CTTN;EMD;AHSA1;KIF5B;DDX6;BZW1;RTN4;CTNNA1;SNX5;PTPRO;GLOD4;RAN;CDH1;TNKS1BP1;SNX1;YWHAE;MB21D2;UBFD1;EZR;PPP1CA;SCRIB;SPTBN1;STX5;EHD1;BAIAP2;KLC2;PSMB6;CDH15;CDH3;PRDX6;CDH22;GOLGA3;MRE11;GCN1;UNC45A;ACVR1;ARGLU1;LYPLA2;TBC1D10A;EIF4G2;USO1;MRTFB;ENO1;ITGB1;EEF1G;NCK1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5183780177084577,-1.2115117382763765,0.2606741573033708,0.7046023727995279,1.0,6/10,37.81%,TATDN1;DCLRE1B;DCLRE1C;EXO1;MGME1;FEN1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3639073733437796,-1.2094875488604913,0.19230769230769232,0.7019506450545815,1.0,14/32,25.56%,SLC6A6;SLC6A9;SLC7A5;SLC25A38;SLC43A2;SLC38A7;SLC1A1;SLC3A2;SLC38A5;SLC1A4;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,voltage-gated chloride channel activity (GO:0005247),0.5836479463912502,1.2087029692818163,0.2733812949640288,1.0,1.0,3/10,6.20%,ANO6;CLCN2;CLCN1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.43209395509860593,1.208219285621274,0.2180028129395218,0.9963022299752995,1.0,12/46,14.37%,MGAT3;OGT;B3GALT1;GCNT4;B4GAT1;B3GLCT;EXTL2;GCNT2;PIGA;HEXA;EXT1;HEXB
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5649405166628224,1.206299468195125,0.25506756756756754,0.9940063413228089,1.0,7/10,29.96%,TNFAIP3;STAMBPL1;STAMBP;CYLD;OTUD4;DESI2;OTUD5
prerank,mRNA methyltransferase activity (GO:0008174),-0.4729475609588598,-1.205287468563579,0.22673031026252982,0.7055257064261713,1.0,8/12,36.41%,NSUN2;TRMT61B;METTL16;METTL8;CMTR2;METTL14;TRMT61A;TRMT10C
prerank,zinc ion binding (GO:0008270),-0.259202029821,-1.2039828302573463,0.03571428571428571,0.7004913842360088,1.0,50/293,10.29%,SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;PAPPA;ENPP2;PHF8;KDM2B;SAMHD1;CHD4;PDXK;UBA5;MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;NAPEPLD;LITAF;RPS29;ENPP3;CXXC5;ACE;RPS27;GRIN2B;KLF4;BLM;RNF125;UPB1;RBSN;ZFP37;RPH3A;ARIH1;MNAT1;GCH1;ZCCHC4;PDE2A;RNF11;PRDM2;USP33;TRIM28;TES
prerank,ATPase activator activity (GO:0001671),-0.4171944945081711,-1.2035110736237533,0.1983695652173913,0.6929356981093666,1.0,5/20,10.41%,DNAJC1;DNAJB2;DNAJA1;ATP1B1;ATP1B2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4939951830218322,1.2000410099196421,0.2540453074433657,1.0,1.0,10/18,18.39%,SOCS5;WDR81;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;WDR91;SOCS2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4759849349799041,-1.1981535008448798,0.2688679245283019,0.6995421598964897,1.0,4/12,13.36%,PIK3R3;PIK3R6;PIK3C2A;IPMK
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.39288882952443827,1.19595548765102,0.2339622641509434,1.0,1.0,11/75,10.59%,RDH10;EHHADH;RDH5;MDH1B;HADHB;DHRS4;ADH5;HSD17B4;AKR1B10;MDH1;KCNAB1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5089735967050426,-1.1949253040573549,0.2429245283018868,0.7005788951372809,1.0,8/10,45.06%,LACC1;CDA;GDA;ADA;DCTD;ADARB2;CDADC1;APOBEC1
prerank,C-C chemokine receptor activity (GO:0016493),0.4857536101965551,1.1940687848222076,0.2473444613050076,1.0,1.0,1/21,0.80%,ACKR3
prerank,ribosome binding (GO:0043022),-0.3348775460226655,-1.1908800535963342,0.18067226890756302,0.7038678771394616,1.0,22/46,25.41%,CPEB4;EIF3C;NOMO1;NAA15;CPEB2;SEC61B;ZC3H12A;EIF2A;YTHDF1;SERBP1;NCLN;MRPS27;RACK1;CPEB1;MAIP1;TMCO1;C1QBP;EEF2;SHFL;OXA1L;YTHDF3;GEMIN5
prerank,hormone activity (GO:0005179),0.41379950111635877,1.1868562070473163,0.24966974900924702,1.0,1.0,5/54,4.80%,INHBB;INSL6;GNRH1;PTHLH;APLN
prerank,pre-mRNA binding (GO:0036002),0.4529475138182506,1.183152946592606,0.2728592162554427,1.0,1.0,8/28,17.59%,RNPC3;CELF1;ZRSR2;RBM22;CELF2;CELF4;TRA2B;SLU7
prerank,adenyl nucleotide binding (GO:0030554),0.5417087551255055,1.1802683381430905,0.27816901408450706,1.0,1.0,3/11,7.30%,HSPH1;SIL1;BAG3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5417087551255055,1.1802683381430905,0.27816901408450706,1.0,1.0,3/11,7.30%,HSPH1;SIL1;BAG3
prerank,hydro-lyase activity (GO:0016836),0.42623556979493815,1.1793926691186443,0.2480106100795756,1.0,1.0,12/41,17.82%,EHHADH;CYP2S1;HADHB;HACD4;HSD17B4;HACD2;GMDS;NAXD;ENO3;PCBD2;ENO2;CDYL
prerank,ion gated channel activity (GO:0022839),-0.38888295628452674,-1.1761812022787408,0.21390374331550802,0.7384962442413044,1.0,10/24,20.92%,ANO1;ANO4;ANO3;KCNT1;TTYH2;TMEM63B;TTYH3;ANO5;TTYH1;ANO2
prerank,glutamate receptor binding (GO:0035254),-0.4320736644793284,-1.1761492427959375,0.22055137844611528,0.7296924382943617,1.0,6/17,8.44%,HIP1;SHANK3;GNAS;SQSTM1;IGSF11;CAMK2A
prerank,anion transmembrane transporter activity (GO:0008509),-0.4788599388544378,-1.1754105391581526,0.26715686274509803,0.7232418127687728,1.0,3/12,3.55%,ABCG2;SLC39A8;SLC22A6
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4982052706886532,1.1744415697983324,0.29296235679214405,1.0,1.0,5/16,13.71%,TDG;NTHL1;SARM1;OARD1;ADPRS
prerank,protein kinase inhibitor activity (GO:0004860),0.41707653003504025,1.1738489398167054,0.25176803394625175,1.0,1.0,18/42,22.66%,PARVA;SPRED1;SPRY4;IBTK;GMFB;MAPK8IP1;HEXIM1;SPRED2;CDKN1C;CIT;SOCS1;INKA2;RPTOR;GSKIP;NCK1;CEP43;TAOK3;YWHAB
prerank,3'-5' DNA helicase activity (GO:0043138),-0.42528643547411404,-1.1679825697839468,0.26288659793814434,0.7365703722441672,1.0,4/16,7.09%,WRN;NAV2;BLM;MCM6
prerank,GTPase activator activity (GO:0005096),0.33726843129587986,1.1649660388237115,0.1697530864197531,1.0,1.0,39/313,6.47%,ARHGAP42;SIPA1L1;DOCK9;DLC1;ARHGEF28;RGS6;DOCK5;RGS14;ARHGAP31;PLCE1;ARHGAP18;ARHGAP32;GRTP1;PSD;RAPGEF3;RAP1A;ARAP1;ARHGAP9;RGL1;RAB3IL1;DOCK1;DENND2D;SGSM2;DENND2C;NF1;AKAP13;OPHN1;EIF2B3;RACGAP1;VAV2;GNAQ;NUCB1;WDR41;HPS1;RAPGEF4;DOCK2;ARHGEF5;RAB3GAP2;ARHGAP26
prerank,transition metal ion binding (GO:0046914),-0.24148792659301932,-1.1643404897446472,0.047619047619047616,0.7390428420866382,1.0,78/397,13.62%,MOXD1;SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;NOS3;PAPPA;MPPED2;ENPP2;PHF8;KDM2B;FTH1;SAMHD1;CHD4;WRN;PDXK;ATP7A;UBA5;MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;COMMD1;HMGCL;NAPEPLD;LITAF;RPS29;ENPP3;LACC1;CXXC5;ACE;FTL;SOD3;RPS27;AOX1;GRIN2B;KLF4;BLM;RNF125;UPB1;SLC11A2;RBSN;ZFP37;RPH3A;ARIH1;MNAT1;GCH1;ZCCHC4;ADCY2;PDE2A;RNF11;PRDM2;USP33;TRIM28;TES;B4GALT1;BMI1;B4GALT7;ETHE1;DPP3;SEC23A;NFU1;NUDT12;LOXL3;ME1;CALB1;ABCE1;KDM7A;ADH1A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5050558638340918,1.1595925706735504,0.32160804020100503,1.0,1.0,5/15,12.83%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3309730634054373,1.1594755016320255,0.11634904714142427,1.0,1.0,70/597,11.47%,MEOX2;BNC2;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;RUNX2;ETV5;GLI2;HOXB6;TEF;CHD3;SPI1;KLF3;FOXK1;BEND3;FOXO3;NPAS2;SOX9;CREB3L1;GLIS2;KLF10;HDAC4;BHLHE40;SP3;ZFP1;ONECUT1;ORC5;CTCF;TBX2;NCOR1;HIC1;PAX3;HOXC10;ONECUT3;MAFG;RARA;SUV39H1;PKNOX2;USF2;LHX6;FOXK2;ISL1;TBX18;LIN28B;HMGB1;FOXJ1;RORB;POU4F1;DBP;ORC3;TLX3;TFEB;RARG;EN2;MZF1;EGR1
prerank,C-C chemokine binding (GO:0019957),0.4666097658762585,1.1589669951140797,0.28700906344410876,1.0,1.0,1/22,0.80%,ACKR3
prerank,fatty acid synthase activity (GO:0004312),0.5455269262419323,1.1584835436658958,0.31523642732049034,1.0,1.0,4/10,13.02%,ELOVL5;ELOVL1;ELOVL2;ELOVL6
prerank,metalloendopeptidase activity (GO:0004222),0.37643736714008924,1.154442682799948,0.2662420382165605,1.0,1.0,19/76,16.33%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;MMP15;ADAMTS19;ADAM10;ADAMTS2;MMP12;MME;MMP16;ADAMTSL4;MIPEP;MMP14;NLN;ZMPSTE24;ADAMTS20
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.47048909016688883,-1.1516596056778914,0.31139240506329113,0.7699608746734804,1.0,3/12,13.69%,POU2F1;HDAC1;TBPL1
prerank,phospholipase C activity (GO:0004629),0.45689164280129296,1.150379844384899,0.300462249614792,1.0,1.0,4/25,3.78%,PLCD3;PLCE1;PLCB3;PLCL1
prerank,chemokine activity (GO:0008009),-0.3567351448953901,-1.1495125655288645,0.24398625429553264,0.767791778185427,1.0,23/31,52.06%,CXCL16;CXCL12;CCL13;CCL19;CXCL10;CCL2;CCL25;CCL28;CCL15;CCL5;CCL4;PF4;PPBP;CCL8;CXCL5;CXCL1;CKLF;CCL7;CCL1;CCL3;CCL11;CXCL13;CXCL2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3496835581871039,1.1481920392272527,0.23085585585585586,1.0,1.0,22/147,6.27%,DOCK9;ARHGEF28;DOCK5;PLCE1;PSD;RAPGEF3;RAP1A;RGL1;RAB3IL1;DOCK1;DENND2D;DENND2C;AKAP13;EIF2B3;VAV2;NUCB1;WDR41;HPS1;RAPGEF4;DOCK2;ARHGEF5;RAB3GAP2
prerank,regulatory RNA binding (GO:0061980),0.42239156410199236,1.14516475106571,0.2920592193808883,1.0,1.0,17/38,25.81%,DND1;PIWIL2;RBM10;TLR7;ZNF346;AGO1;DICER1;PUM2;SPOUT1;DHX9;PUM1;ELAVL1;ZC3H7B;FMR1;DDX21;PNPT1;AGO2
prerank,adenyl ribonucleotide binding (GO:0032559),-0.23885759237621834,-1.1445316419644505,0.11764705882352941,0.7744009039312834,1.0,69/291,16.50%,PRKAG2;DAPK1;KSR1;RAPGEF2;INSR;MYO1B;MAP3K20;ENPP1;MARK1;MPPED2;LATS2;MTHFS;MYO6;SNRK;TGFBR1;PDXK;ATP7A;AKT3;RPS6KA5;ACVRL1;STK17B;RHOBTB3;SIK1;BLM;TRNT1;SMC4;HSPA8;TWF1;ABCC6;HARS1;MCM6;ABCD4;PDE10A;UBA2;TAP2;SYN1;MKNK2;CDK6;AKT1;MYH10;PDE2A;CDKL5;VPS4A;TRIB1;OXSR1;MKNK1;ACLY;ABCD2;SMARCA5;PMVK;SYN3;ME1;ABCA2;PDE4A;MYO18A;SPHK1;ABCE1;PXK;MTHFD1L;MTPAP;HACL1;ABCG1;P2RX7;MVK;PEX6;P2RX4;NOL9;EIF4G1;PEX1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.33644625764063807,1.1444427784448659,0.23675675675675675,1.0,1.0,30/254,10.20%,MEOX2;KLF5;ETV4;ETV1;FOXD2;POU4F3;NFATC1;ETV5;NFIA;FOXO3;SOX9;PGR;REL;CREB3L1;GLIS2;ZNF585B;ZNF585A;KLF10;ONECUT1;NRF1;ZFP62;HOXC10;RREB1;FOXK2;E4F1;PLSCR1;SMARCD2;FOXJ1;POU4F1;DBP
prerank,cation:chloride symporter activity (GO:0015377),0.5327875081743614,1.140964699031551,0.3260135135135135,1.0,1.0,3/10,4.40%,SLC12A2;SLC12A4;SLC12A3
prerank,sodium channel regulator activity (GO:0017080),0.4135309793943649,1.1404120001145728,0.308659217877095,1.0,1.0,8/37,11.99%,NEDD4L;CAMK2D;GPLD1;ATP2B4;SCN2B;FXYD6;NEDD4;SGK1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4510860135474066,1.1404051508167694,0.2916666666666667,1.0,1.0,1/28,0.24%,EDA
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4246596148968045,-1.138510983631564,0.302158273381295,0.7746151301559836,1.0,8/16,20.92%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.4246596148968045,-1.138510983631564,0.302158273381295,0.7746151301559836,1.0,8/16,20.92%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,inward rectifier potassium channel activity (GO:0005242),0.4434118169322283,1.1379108304123406,0.3189522342064715,1.0,1.0,4/24,5.75%,KCNJ4;KCNJ16;KCNK1;KCNJ13
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4692865123434078,1.1371058185930307,0.3122977346278317,1.0,1.0,4/18,8.91%,ALDH1A3;ALDH9A1;ALDH18A1;AKR1B10
prerank,glutathione transferase activity (GO:0004364),0.4564617499344196,1.1367970661577937,0.3149847094801223,1.0,1.0,6/23,12.09%,MGST2;GSTA4;GSTZ1;GSTK1;GSTA3;LANCL1
prerank,chemoattractant activity (GO:0042056),0.4405078329162687,1.1353528093103693,0.30362537764350456,1.0,1.0,1/26,0.26%,FGF7
prerank,monocarboxylic acid binding (GO:0033293),0.4750060026655727,1.131192468161588,0.34796747967479674,1.0,1.0,2/18,7.54%,NR2F2;RARA
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.30394358276718897,-1.1297325209715499,0.22868217054263565,0.792315149074487,1.0,21/53,23.69%,SLC7A11;SLC47A1;SLC6A9;SLC7A5;SLC7A1;SLC7A6;SLC15A4;SLC25A38;CTNS;SLC43A2;SLC38A7;SLC1A1;SLC1A3;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC1A4;SLC38A1;SLC38A9;SLC7A10
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5089208040296924,1.1296321257854727,0.3200663349917081,1.0,1.0,2/12,4.87%,B3GALT1;B4GAT1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4512674131935587,1.1292650877476704,0.3189522342064715,1.0,1.0,3/23,1.49%,PLCD3;PLCE1;PLCB3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4970342903126949,1.1265823110250333,0.33878887070376434,1.0,1.0,8/14,24.83%,POP4;POP7;TSEN34;RPP14;RPP21;RPP30;TSEN2;PRORP
prerank,dynactin binding (GO:0034452),0.5240450328396091,1.1250929252822606,0.32148900169204736,1.0,1.0,5/12,14.84%,PAFAH1B1;GSK3B;HOOK3;HTT;SNX5
prerank,SUMO transferase activity (GO:0019789),0.47889348465882803,1.1213977594296347,0.3393739703459638,1.0,1.0,4/16,11.55%,UBE2I;HDAC4;PIAS2;RANBP2
prerank,cytokine receptor binding (GO:0005126),-0.2776434357762396,-1.1173733693420016,0.22564102564102564,0.821215413016337,1.0,16/83,13.01%,SMAD3;OSMR;IL13RA1;TGFBR3;IL6R;FKBP1A;IL1RAP;IL18;LIFR;TRAF6;CXCL12;JAK2;VEGFC;VEGFD;IL34;TGFB2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.42360938515815616,1.115981692692657,0.3197080291970803,1.0,1.0,9/31,14.98%,SLC12A2;SLC12A4;SLC12A3;KCNK1;KCNK5;AQP1;KCNK4;KCNK10;SLC12A8
prerank,pseudouridine synthase activity (GO:0009982),0.48588848043098665,1.11286299221601,0.3645655877342419,1.0,1.0,3/13,6.65%,RPUSD2;PUS7;PUS3
prerank,manganese ion binding (GO:0030145),0.3848174293775035,1.1126362575831759,0.33067729083665337,1.0,1.0,5/48,6.50%,FAM20C;ARG1;XYLT2;PPM1M;ABL2
prerank,ATP binding (GO:0005524),-0.23536624168212716,-1.111933238638314,0.15,0.8285836952161091,1.0,62/266,16.50%,PRKAG2;DAPK1;KSR1;INSR;MYO1B;MAP3K20;ENPP1;MARK1;LATS2;MTHFS;SNRK;TGFBR1;PDXK;ATP7A;AKT3;RPS6KA5;ACVRL1;STK17B;RHOBTB3;SIK1;BLM;TRNT1;SMC4;HSPA8;TWF1;ABCC6;HARS1;MCM6;ABCD4;UBA2;TAP2;SYN1;MKNK2;CDK6;AKT1;MYH10;CDKL5;VPS4A;TRIB1;OXSR1;MKNK1;ACLY;ABCD2;SMARCA5;PMVK;SYN3;ABCA2;MYO18A;SPHK1;ABCE1;PXK;MTHFD1L;MTPAP;HACL1;ABCG1;P2RX7;MVK;PEX6;P2RX4;NOL9;EIF4G1;PEX1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.46070687319108156,-1.1118796358509169,0.3416289592760181,0.820048957988753,1.0,6/11,29.16%,LEF1;GATA2;ZXDC;EHMT2;TAF9;THAP7
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.26775470760363956,-1.1080016270743887,0.2215909090909091,0.8236404234204433,1.0,25/100,11.50%,HIP1;PARD3;OSBPL8;ADAP2;MYO1B;CYTH3;SNX21;COMMD1;ZFYVE28;ARAP3;MYO10;DAPP1;HIP1R;KCNH1;SNX24;RPH3A;FCHSD2;WIPI1;AKT1;OSBPL5;RUBCN;IQGAP2;TECPR1;DENND1A;PLEKHF1
prerank,frizzled binding (GO:0005109),0.41433409057069137,1.107058895265911,0.3226256983240223,1.0,1.0,8/34,14.16%,WNT10A;WNT2B;WNT16;WNT5A;ZNRF3;DVL3;WNT9A;FZD7
prerank,RNA polymerase binding (GO:0070063),-0.3939230631384164,-1.103923146815606,0.31607629427792916,0.8275474284778894,1.0,11/18,25.15%,YTHDC2;CCNT2;CCNT1;STOM;PHRF1;PPIB;ZFP36;SCAF8;ANP32B;BRCA1;TCERG1L
prerank,calcium channel regulator activity (GO:0005246),-0.32972409425153953,-1.1027945367231298,0.2809364548494983,0.8223014035253533,1.0,9/37,15.12%,ITPR1;PRKG1;FKBP1A;CALM1;CACNG7;NRXN1;REM1;NRXN2;SRI
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.42922113028143666,-1.1024204305266916,0.35083532219570407,0.8151068074058481,1.0,5/13,16.69%,PIP5K1B;PIK3C2A;PIP4K2A;PIP4K2C;PIP5K1A
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4309199660598191,-1.1018850485921334,0.3223350253807107,0.8086007277538868,1.0,6/12,29.80%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3304359850433519,-1.0997299621409937,0.30407523510971785,0.8068784860623012,1.0,7/35,4.43%,PLCB4;GPCPD1;ENPP1;MPPED2;ENPP2;NAPEPLD;ENPP3
prerank,cation channel activity (GO:0005261),0.35100704925938175,1.0982983165294087,0.3108265424912689,1.0,1.0,18/94,14.27%,PIEZO2;OTOP1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;KCNK1;SLC4A11;PIEZO1;KCNK5;ANO10;AQP1;PKD1;TRPV2;KCNK4;KCNK10;TMEM63A
prerank,nucleotide diphosphatase activity (GO:0004551),-0.4163950826981021,-1.0980312193524726,0.33729216152019004,0.8044708217392149,1.0,7/14,21.15%,ENPP1;NUDT13;NUDT3;ENPP4;NUDT12;NUDT11;CILP
prerank,protein tyrosine kinase binding (GO:1990782),0.3597265749376482,1.0965756530807735,0.3227848101265823,1.0,1.0,10/71,9.21%,LRP4;CEACAM1;SOCS5;CDH5;ITGAX;TJP2;PTPN14;BANK1;PIK3R2;CBLB
prerank,pyridoxal phosphate binding (GO:0030170),-0.3763529425707316,-1.0939797936915803,0.3463687150837989,0.807926286817249,1.0,13/20,34.44%,PDXK;CBS;PYGB;ACCS;AGXT;CTH;OAT;PNPO;PYGL;THNSL2;SHMT2;SHMT1;PYGM
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3598339536625841,-1.0937746363512397,0.2991202346041056,0.8006921295707271,1.0,11/24,24.46%,LARP6;RPS7;RPL26;RPL41;MYH10;NCL;DHX36;MRPS11;GNL3;RPL5;RPS14
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.34492712258367003,-1.0927511517489932,0.2988165680473373,0.7958504796559709,1.0,10/27,22.32%,MED21;POLR3B;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F
prerank,myosin binding (GO:0017022),-0.2964116866160461,-1.0916164962915165,0.2938775510204082,0.7912469806951735,1.0,12/55,19.54%,MYRIP;DMD;RAB6B;RAB3C;LARP6;TRIOBP;RAB11A;LLGL2;RAB3B;NKD2;RAB11B;MLPH
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.48533616993506923,1.0912874108962352,0.3595317725752508,1.0,1.0,2/13,5.92%,RGS14;GDI1
prerank,leak channel activity (GO:0022840),0.4597177935156479,1.0901456824331124,0.35526315789473684,1.0,1.0,5/18,14.25%,NALCN;KCNK1;KCNK5;KCNK4;KCNK10
prerank,death domain binding (GO:0070513),0.5026659818220475,1.0891463724621853,0.37948717948717947,1.0,1.0,5/11,21.55%,TRADD;MCL1;IRGM;BAX;DAP
prerank,glycine binding (GO:0016594),-0.4460120861228611,-1.0890556747444853,0.3747016706443914,0.7908534259153345,1.0,4/11,11.47%,GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,calcium channel inhibitor activity (GO:0019855),-0.44546584817679,-1.08739008026097,0.36961451247165533,0.7882339103907083,1.0,3/11,6.38%,ITPR1;FKBP1A;CALM1
prerank,calcium channel activity (GO:0005262),-0.27149000983229743,-1.0870143234197902,0.30177514792899407,0.7819915206657219,1.0,26/84,26.41%,CACNA2D3;SLC24A3;TRPC3;TRPC1;CACNB2;ANXA2;ORAI1;GRIN1;CACNG7;TRPC7;TRPM7;P2RX4;ANXA6;CACHD1;TRPM2;OPRM1;CACNA2D4;STIM2;TMCO1;TPCN2;CACNG4;PKD2L1;ANXA9;PKD2L2;CACNA1B;PKD1L3
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2360266585042881,-1.085468818689198,0.20408163265306123,0.7788333082729378,1.0,45/189,17.23%,SMAD3;RUNX1T1;RBPJ;MEF2D;PPARD;TBX3;LMO2;CHD4;EP300;PRDM5;CRTC3;CXXC5;RBL1;SIK1;NPM1;KLF4;HDAC7;HDAC9;HIRA;MEF2A;PRDM16;HDAC1;PTMA;CREB1;MAP3K10;PIAS3;AR;NFYB;CRTC2;ATF2;KDM1A;SP1;BBS2;NOC2L;TAL1;ID2;YWHAZ;MKKS;MYOCD;RBL2;TLE5;HHEX;MTDH;HSPB1;DDX20
prerank,ion channel inhibitor activity (GO:0008200),0.39774725908569397,1.0844164018450893,0.3588652482269504,1.0,1.0,7/35,12.36%,NEDD4L;CAMK2D;STX1A;FKBP1B;NEDD4;VAMP8;ENSA
prerank,gamma-tubulin binding (GO:0043015),0.44160607993695555,1.0816660814138173,0.37037037037037035,1.0,1.0,9/21,22.16%,RACGAP1;BRSK1;TUBGCP5;RAB11FIP5;B9D2;ARHGEF7;OFD1;TUBGCP6;BLOC1S2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4531567961335813,-1.0815010597030006,0.3788546255506608,0.7832019382929075,1.0,3/10,2.75%,SLC24A3;SLC8A3;SLC8A1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.4096956153296786,-1.0808833682879782,0.3798449612403101,0.7776778035064505,1.0,6/13,19.68%,SLC7A1;SLC7A6;SLC15A4;SLC38A7;SLC38A5;SLC25A29
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3255902615339207,-1.0806717946767885,0.32,0.7714350451845584,1.0,9/34,14.98%,FAM20A;IGF2;CCNT2;CALM1;MAP2K2;CCNT1;RICTOR;CDK5R1;CALM3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.43697687053831213,1.079948943250912,0.36577708006279436,1.0,1.0,4/21,6.57%,CDK15;CDKL3;CDK13;CDK7
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.43697687053831213,1.079948943250912,0.36577708006279436,1.0,1.0,4/21,6.57%,CDK15;CDKL3;CDK13;CDK7
prerank,GDP binding (GO:0019003),0.3613903098441925,1.0791430525109524,0.3494132985658409,1.0,1.0,20/63,22.78%,RAP1A;RAB8B;RAB29;MRAS;RASEF;NRAS;KRAS;ARF6;MIEF1;ARL8B;RAN;RAB21;GEM;RAB27B;RAB5A;RALA;RAB18;RHEBL1;GNAI3;RAB9A
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.39391001227601014,1.0783474612438357,0.36,1.0,1.0,13/37,20.14%,RARS2;TARS2;CARS2;VARS1;DARS1;KARS1;WARS1;TARS1;SARS2;DARS2;WARS2;HARS2;TARS3
prerank,poly(U) RNA binding (GO:0008266),0.44503245085836396,1.0756488154690773,0.375594294770206,1.0,1.0,4/20,7.79%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.46386831015718866,1.074698094377681,0.3606837606837607,1.0,1.0,4/13,11.07%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,lysophospholipase activity (GO:0004622),-0.36315831047620273,-1.0724794639931428,0.3424657534246575,0.7881456204188938,1.0,5/20,14.68%,ENPP2;LYPLA1;ASPG;PNPLA6;LYPLAL1
prerank,PDZ domain binding (GO:0030165),0.3680068682057311,1.0719762228149041,0.3761232349165597,1.0,1.0,4/61,1.71%,CXADR;F11R;KCNJ4;FZD2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.45977311786115704,1.0703086699037971,0.3825503355704698,1.0,1.0,9/15,21.15%,SOCS5;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;SOCS2;CISH
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5015921379532707,1.068403963787918,0.3963963963963964,1.0,1.0,3/10,8.22%,FAP;NAALAD2;DPP4
prerank,actin monomer binding (GO:0003785),0.4350078572681493,1.0683711051306592,0.39215686274509803,1.0,1.0,4/22,10.73%,PRKCE;COBL;ABL2;MTSS1
prerank,protein homodimerization activity (GO:0042803),0.30168832582781474,1.0671025930625817,0.29417670682730923,1.0,1.0,125/589,17.66%,TENM2;ALDH1A3;F11R;INHBB;STC2;FGFR1;NR2F2;FOXP2;CEACAM1;FAP;CAMK2D;SLC8B1;AXIN1;PDLIM4;SLC39A13;GLCE;RDH5;MSH6;TDG;FXR2;KIF20B;NAGA;KMT2A;CAV2;TPD52;AADAT;ADD1;PHETA2;PAXX;S100A6;IRAK3;PIP4K2B;ATIC;BHLHE40;TSG101;CEP131;CLCN1;TRIM21;ADAM10;RABEP1;TMEM192;HOGA1;NRF1;TARS2;MCL1;NLRC4;MSH2;USF2;MAP3K5;HSD17B4;DPP4;S100B;DEFA6;TBX18;ST6GAL1;PDCD6IP;RPE;COQ9;PLEK;CASQ2;INPP5F;CUBN;PTPRT;CHMP4B;CHMP4A;CANT1;KARS1;GLDC;ADRA2A;GSTA4;GSTZ1;TPR;XPNPEP3;RCHY1;KLHL7;MME;PAFAH1B2;MZF1;SNX2;DGCR8;EFEMP2;PRPS1;PRPS1L1;CHMP4C;PGRMC1;CRPPA;PTPA;MAP3K21;ABCD1;GEN1;ABCB7;ATG7;MYOM3;STARD3;AIMP1;ERN1;EXT1;SFPQ;FXR1;FZD9;TXN;ERBB4;TMEM266;ABCB9;PTPRO;NECTIN3;MTMR1;ADCY8;TRIM5;LPL;SNX1;TESC;SCARB2;EXT2;WARS1;KYAT1;DCK;PRKRA;CAMK2G;ALS2;CEP57;MAP3K9;BNIP3;TERF2;MIGA1
prerank,endopeptidase activity (GO:0004175),0.31227141785453977,1.0660106709607433,0.35721812434141204,1.0,1.0,53/257,17.70%,ADAMTS14;CORIN;MMP28;CTRC;ADAMTS12;FAP;ADAMTSL5;KLK2;ADAMTS1;PCSK5;ADAM19;MMP15;CD5L;ADAMTS19;USP8;ADAM10;ADAMTS2;USP48;DPP4;PSMB5;PCSK7;USP47;BACE2;USP13;MMP12;MME;CELA1;PROC;TASP1;MMP16;KDM8;USP15;ADAMTSL4;MIPEP;HTRA2;PSMA6;PSMB2;PSMA2;USP35;MMP14;PLG;NLN;TYSND1;PSMA7;ZMPSTE24;ADAMTS20;MBTPS1;BACE1;CTSB;USP37;MASP2;USP9X;RHBDF1
prerank,WW domain binding (GO:0050699),-0.3403037188685068,-1.0655883969487498,0.3465346534653465,0.8006512390513311,1.0,3/26,4.13%,RAPGEF2;TNK2;LITAF
prerank,mRNA 3'-UTR binding (GO:0003730),0.3511831812864709,1.0639613385632491,0.371571072319202,1.0,1.0,16/79,14.39%,HNRNPC;FXR2;DND1;CELF1;HNRNPA0;PABPC4L;SECISBP2;PABPC4;TUT1;IGF2BP2;ELAVL2;CELF2;ILF3;ZFP36L2;FXR1;PUM2
prerank,semaphorin receptor activity (GO:0017154),-0.437476609546282,-1.063849805777866,0.35731414868105515,0.7986357466321422,1.0,2/11,1.31%,PLXNA2;PLXNA4
prerank,chemorepellent activity (GO:0045499),-0.3457114173657102,-1.0624130332951776,0.36085626911314983,0.7959422207520123,1.0,5/25,4.84%,EPHA7;SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4522843749154307,1.062316464286923,0.39872408293460926,1.0,1.0,6/17,9.87%,ATP8B1;PITPNC1;PCTP;ABCA1;ATP8B2;ATP10B
prerank,general transcription initiation factor binding (GO:0140296),-0.34534687433028305,-1.0592877308864863,0.3626062322946176,0.7977025852643854,1.0,10/25,29.16%,RUVBL1;AR;ESR1;DRAP1;AHR;HHEX;DR1;PSMC5;TAF11;THAP7
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.49800306922985654,1.056548439400124,0.39663865546218485,1.0,1.0,1/11,0.65%,SGMS2
prerank,steroid hydroxylase activity (GO:0008395),0.4668485898239352,1.05588351918022,0.4061990212071778,1.0,1.0,2/16,3.88%,CYP7B1;CYP2S1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4455140067708781,1.0549541117922847,0.37437603993344426,1.0,1.0,4/15,11.07%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,peptidoglycan binding (GO:0042834),-0.4549051468201775,-1.0541415252281805,0.4236559139784946,0.8049814169796268,1.0,6/10,41.90%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.4567790770024916,1.053837886559106,0.4103852596314908,1.0,1.0,3/15,7.25%,SLC4A3;SLC26A9;SLC4A11
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4396540287748613,-1.0538298263126766,0.41705069124423966,0.799032748924909,1.0,3/10,13.49%,PHF8;KDM2B;KDM7A
prerank,tau-protein kinase activity (GO:0050321),-0.34951761352337696,-1.0490165373552367,0.38461538461538464,0.8058679599653347,1.0,5/20,12.20%,ROCK2;MARK1;GSK3A;TTBK1;TAOK2
prerank,chemokine receptor activity (GO:0004950),0.41473914563926056,1.0479297714709,0.39970717423133234,1.0,1.0,1/24,0.80%,ACKR3
prerank,potassium channel regulator activity (GO:0015459),0.3666707423430882,1.0464508291506776,0.4048913043478261,1.0,1.0,12/49,20.15%,NEDD4L;KCNIP4;KCNS3;KCNAB1;SLC5A3;SGK1;ENSA;YWHAE;CHP1;SUMO1;ADRB2;KCNIP1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.46570827545331456,1.0459157644133419,0.40663176265270506,1.0,1.0,2/12,6.59%,OPN1MW;OPN1MW3
prerank,ion channel activity (GO:0005216),0.3402987956312324,1.0423222789498623,0.41874258600237246,1.0,1.0,11/80,9.99%,PIEZO2;NALCN;TRPM3;GRIA3;TRPV4;TMC2;CNGB1;PIEZO1;GRID1;TMC4;GRIA1
prerank,metallopeptidase activity (GO:0008237),0.327148636126021,1.0401970722699625,0.41445783132530123,1.0,1.0,24/113,16.72%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;BRCC3;MMP15;ADAMTS19;RNPEP;ADAM10;ADAMTS2;LNPEP;MMP12;MME;MMP16;ADAMTSL4;MIPEP;MMP14;COPS5;NLN;ZMPSTE24;ADAMTS20;BMP1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3518981589409292,1.0393301531494274,0.39169909208819714,1.0,1.0,8/56,9.21%,LRP4;SOCS5;ITGAX;PTPN14;TRADD;PIK3R2;GAB2;CBLB
prerank,myosin V binding (GO:0031489),-0.3866953064635661,-1.0392565846455994,0.4381188118811881,0.8262203977158723,1.0,6/15,23.25%,RAB6B;RAB3C;RAB11A;RAB3B;RAB11B;RAB10
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3489793414217053,1.0392007952138342,0.39405684754521964,1.0,1.0,16/69,15.63%,MOGAT2;CERS6;MOGAT3;AWAT2;KAT6B;PLAAT5;ZDHHC1;SOAT1;ZDHHC7;CREBBP;ZDHHC13;ZDHHC20;KAT8;ZDHHC8;NAA10;NMT1
prerank,TBP-class protein binding (GO:0017025),-0.35436242151147973,-1.0391374525316943,0.35714285714285715,0.8199640157169021,1.0,6/21,16.91%,RUVBL1;ESR1;DRAP1;AHR;HHEX;DR1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.39340753561637554,1.0391074864130134,0.41930835734870314,1.0,1.0,11/34,10.19%,ARAP1;ARHGAP9;OGT;PHLDA3;RACGAP1;KIF16B;ZFYVE16;OBSCN;GAB2;MAPKAP1;FERMT2
prerank,phospholipase binding (GO:0043274),0.4631634727082788,1.0365188756543247,0.4322469982847341,1.0,1.0,6/13,21.16%,SRC;PAFAH1B1;SYK;BTK;PDPK1;PRKN
prerank,solute:anion antiporter activity (GO:0140323),-0.3913587293734326,-1.0351262320830572,0.3932038834951456,0.8246992413005666,1.0,3/14,6.39%,SLC7A11;SLC26A7;SLC26A2
prerank,FMN binding (GO:0010181),0.47936746760058335,1.034181675371216,0.4381443298969072,1.0,1.0,1/11,0.66%,POR
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.35961358277646926,-1.033030625049988,0.42349726775956287,0.8242636850810452,1.0,5/17,9.29%,GRIA2;GRIN3A;GRIN2B;GRIK2;GRIN1
prerank,DNA binding (GO:0003677),0.2920795549895789,1.0322675444899838,0.4012036108324975,1.0,1.0,126/694,17.22%,RORA;MEOX2;NFATC2;GLI1;PPARGC1A;FOXD2;NR2F2;TSHZ3;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;PBX1;EGFR;MYBBP1A;ETV5;MSH6;TDG;NUFIP1;GLI2;HIVEP2;COLEC11;TFPT;CHD3;PCBP2;HLX;FOXO3;NPAS2;SOX9;WDR76;PGR;CHD8;CHD2;HDAC4;SATB1;NTHL1;BANF2;SMARCAD1;PDS5B;TSG101;GTF3C6;TAF4B;ARID3A;RFC3;STN1;ZDHHC1;NBN;SIRT3;C1D;CTCF;TBX2;PALB2;HIC1;PAX3;MSL3;MSH2;USF2;FOXK2;ILF2;RBM5;JRKL;ZBTB6;SLTM;TET1;MECP2;HMGB1;FOXJ1;ZMYM6;POU4F1;TRNP1;HDAC2;ILF3;SAP30L;MMP12;ERCC6;RARG;LONP1;TDP1;EGR1;INO80;TOP1;ERCC1;ZBTB49;ZNF148;MEN1;ERF;NFE2L2;MTERF2;CREBBP;POGK;CRLF3;NUCKS1;ARID4A;MBD1;CBFB;GTF3C5;CAMTA2;SFPQ;POLG2;RAD51AP2;AIFM2;FOXF1;REXO4;POU6F1;NR5A1;BATF;FAM111A;KMT2D;FOXC2;POLE;DEDD;E2F1;DDB2;BRIP1;SRRT;PPARG;PBX4;TSNAX;HP1BP3;TDP2;QRICH1;RTF1;ESRRA;CUL4B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.42766489213415454,-1.0320324202134579,0.43777777777777777,0.820191862388356,1.0,3/10,20.35%,SETD5;SMYD2;ASH1L
prerank,neurexin family protein binding (GO:0042043),0.4898084307058594,1.0320117630868546,0.44584837545126355,1.0,1.0,2/10,4.84%,CEL;CPE
prerank,adrenergic receptor binding (GO:0031690),-0.37423717376695537,-1.0316276844055419,0.43209876543209874,0.8148626410120833,1.0,2/16,1.09%,RAPGEF2;GNAS
prerank,sulfuric ester hydrolase activity (GO:0008484),0.468376016827577,1.0296329188330458,0.4156521739130435,1.0,1.0,1/12,1.18%,SULF1
prerank,sodium:proton antiporter activity (GO:0015385),-0.4169643311341976,-1.0280985935547053,0.4046511627906977,0.8182393317896131,1.0,5/11,17.36%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4815252172501715,1.0267661393746412,0.45084745762711864,1.0,1.0,2/11,1.47%,ITPR2;ITPR3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.374385932827843,1.0266168257178538,0.4375857338820302,1.0,1.0,3/38,4.78%,SERPINB2;SERPING1;SERPINH1
prerank,copper ion binding (GO:0005507),-0.29248726469059494,-1.0248818032939522,0.40298507462686567,0.8203660309718516,1.0,5/42,5.36%,MOXD1;ATP7A;COMMD1;LACC1;SOD3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3431343005574014,1.0242079556968564,0.40458015267175573,1.0,1.0,3/73,2.84%,SORCS2;MC5R;KISS1R
prerank,lipid phosphatase activity (GO:0042577),0.44792835699758055,1.0224944333195345,0.43050847457627117,1.0,1.0,2/14,4.08%,PLPP2;PLPP3
prerank,protein phosphatase activator activity (GO:0072542),-0.40361758542069315,-1.02140374041698,0.43596059113300495,0.822878953662943,1.0,8/13,32.59%,IGFBP3;CALM1;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,histone acetyltransferase activity (GO:0004402),0.38874576994527726,1.0199792731900683,0.44296296296296295,1.0,1.0,11/30,19.70%,HAT1;KAT6B;TAF10;NCOA3;CREBBP;EPC2;KAT8;TADA2A;MCM3AP;NAA40;NAA60
prerank,phospholipase activity (GO:0004620),0.34048657923262937,1.0187239913935837,0.4313222079589217,1.0,1.0,8/67,8.25%,PLCE1;PLCB3;DDHD1;GPLD1;PLCL1;PLAAT5;PLD3;ABHD12
prerank,RNA polymerase core enzyme binding (GO:0043175),0.37831874097224144,1.0181329010122204,0.427972027972028,1.0,1.0,15/33,22.71%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;ERBB2;SPTY2D1;DHX9;CDC73;CCAR2;PCF11
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.45071307459580445,1.0176476196670932,0.4589041095890411,1.0,1.0,3/13,4.50%,CDH5;SRC;BMP5
prerank,GTPase activity (GO:0003924),0.30187168630931993,1.0163835496631417,0.44468546637744033,1.0,1.0,19/192,9.03%,GNA14;RAP1A;RAB8B;RAB29;MRAS;BMS1;DNM1;MFN2;GNAQ;RAC2;NRAS;KRAS;RHOJ;RAB3A;ATL2;GNL2;IRGM;GNAL;GNG3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.39425578271310635,-1.015788982887015,0.4339152119700748,0.8320817750932418,1.0,4/14,9.18%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,actin binding (GO:0003779),0.3069912425482822,1.0153342160118355,0.4490022172949002,1.0,1.0,25/170,10.73%,UTRN;SORBS1;PARVA;PRKCE;COBL;CEACAM1;TLN2;PDLIM4;CAPZB;SPEF1;TRPV4;ADD1;PPP1R42;SHROOM2;ABL2;RDX;DAG1;TMOD1;MICAL3;CALD1;FLNB;CGN;FERMT2;GC;MTSS1
prerank,poly-pyrimidine tract binding (GO:0008187),0.40903455478444345,1.0141793320425148,0.4398782343987823,1.0,1.0,4/23,7.79%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3909635811138231,1.0121276232160488,0.4366412213740458,1.0,1.0,9/25,9.81%,PHLDA3;SESTD1;KIF16B;PLEKHA4;OBSCN;TTPA;PLEK;GAB2;MAPKAP1
prerank,phosphotyrosine residue binding (GO:0001784),-0.30636149161862347,-1.009555889971522,0.43670886075949367,0.8430734069106547,1.0,10/37,12.48%,PTPN3;PIK3R1;PIK3R3;SHE;CRK;PLCG2;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,BMP receptor binding (GO:0070700),0.4507158884003295,1.0086379703975428,0.4586206896551724,1.0,1.0,3/12,4.50%,CDH5;SRC;BMP5
prerank,deubiquitinase activity (GO:0101005),0.32362450197228315,1.0086002194384576,0.4639423076923077,1.0,1.0,24/88,18.39%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;MINDY3;USP48;USP47;MINDY2;PAN2;USP13;OTUD7B;MINDY4;USP4;USP15;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP37;USP9X;USP53;PSMD14
prerank,magnesium ion binding (GO:0000287),0.30740207571516753,1.0081005235865954,0.45062429057888764,1.0,1.0,40/135,20.35%,XYLT2;MSH6;TDG;STK38;IRAK3;THTPA;DXO;BRSK1;CERK;ABL2;NLRC4;STK38L;CLYBL;MSH2;DIS3L2;PGM1;FOXK2;SRPK1;MAP3K5;PLSCR1;STK3;SRPK2;NUDT18;GEN1;SIK3;PRKACB;ADPRS;ERN1;NT5C3A;RAN;PI4K2A;TESC;TDP2;GEM;DYRK2;PINK1;TKT;CDC42BPG;NUDT5;NME1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.27052813225670685,-1.0076569674774667,0.423728813559322,0.8414227762592058,1.0,8/55,6.49%,SLC24A3;ITPR1;TRPC3;TRPC1;CACNB2;ANXA2;ORAI1;ATP2C1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.2958877117860684,-1.0049624623301279,0.40129449838187703,0.8424759431423761,1.0,7/33,10.48%,RNF217;RNF125;TRAF6;ARIH1;RNF144B;UBA2;RPS3
prerank,neuropeptide receptor binding (GO:0071855),0.4477152183363461,1.003337068838783,0.4418212478920742,1.0,1.0,5/14,27.91%,APLN;AGRP;PPY;SHANK1;NPY
prerank,sodium channel activity (GO:0005272),0.3637761200333413,1.002465973254816,0.4348441926345609,1.0,1.0,5/37,7.25%,SCN10A;KCNK1;CACNA1H;SHROOM2;SLC4A11
prerank,histone demethylase activity (GO:0032452),-0.3120870444027416,-0.9993728418182676,0.44610778443113774,0.85078340133054,1.0,6/27,13.49%,KDM5C;PHF8;KDM2B;JARID2;KDM1A;KDM7A
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3379117254333227,-0.9983179504968388,0.42216358839050133,0.8471755754898718,1.0,4/20,8.27%,SLC30A10;SLC39A10;SLC39A8;SLC39A14
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3909152614967243,-0.9981116676458999,0.46634615384615385,0.8415029300907159,1.0,5/12,17.36%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3449987045334239,0.9973518412537026,0.4679144385026738,1.0,1.0,12/49,11.44%,TNIP3;BRCC3;WDR81;TNFAIP3;UBL7;UIMC1;TNIP1;MINDY2;SHARPIN;OTUD7B;TAB2;HDAC6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.31058555085709316,-0.9953678741716759,0.4397590361445783,0.8430324037451998,1.0,12/28,27.42%,TNK2;RPS6KB1;MAP2K2;AKT1;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;RPS6KA1;MAP2K1;TTK;MAP2K5
prerank,kinase activity (GO:0016301),-0.2358061367530463,-0.9930800685805484,0.4689655172413793,0.8429406207088579,1.0,26/109,15.63%,NADK2;CHKA;LYN;EPHA4;PDXK;CKB;PGM2L1;PAPSS1;ETNK1;AKT1;PIK3C2A;CAMK2A;DGKB;CDKL5;FCSK;PANK1;LRRK2;PMVK;CSNK2A1;SPHK1;IPMK;CDC7;DGKK;SEPHS1;CDK5R1;MVK
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.31023771667593103,-0.9919754234082205,0.47761194029850745,0.8399761826000661,1.0,5/27,7.09%,RNF217;RNF125;TRAF6;ARIH1;RNF144B
prerank,RNA stem-loop binding (GO:0035613),-0.3926307904872669,-0.9918715211953206,0.4567307692307692,0.834263272358725,1.0,5/12,18.88%,LARP6;MYH10;ZC3H12A;RC3H1;METTL16
prerank,ribonuclease P activity (GO:0004526),0.4629377456714409,0.9912256812247511,0.4750430292598967,1.0,1.0,6/11,24.83%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,anion channel activity (GO:0005253),0.3310691553274286,0.9900816247370297,0.4482758620689655,1.0,1.0,9/61,12.09%,VDAC2;LRRC8D;SLC26A9;ANO6;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.24398459588620386,-0.9896972532650419,0.4725274725274725,0.8347987494933211,1.0,14/78,11.79%,CTSH;USP28;CAPN15;USP1;CTSL;USP20;CASP3;USP42;USP18;LGMN;CFLAR;USP33;USP36;CASP12
prerank,protein kinase C activity (GO:0004697),0.43711343432452254,0.9884255868258759,0.44761904761904764,1.0,1.0,2/14,4.02%,PRKCE;PRKCA
prerank,MAP kinase phosphatase activity (GO:0033549),-0.39856170480798403,-0.9879396043522275,0.49056603773584906,0.8334457735450127,1.0,4/12,21.71%,DUSP10;DUSP3;DUSP7;DUSP1
prerank,palmitoyltransferase activity (GO:0016409),0.3834100105348525,0.9875696187887418,0.4660633484162896,1.0,1.0,13/28,23.04%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,microtubule motor activity (GO:0003777),0.34068079997883494,0.9848604935052547,0.46604527296937415,1.0,1.0,10/51,13.22%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF5A;KIF26A;KIF5B
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28633153318269555,0.9846523303748654,0.5078369905956113,1.0,1.0,25/248,9.03%,GNA14;KIF2A;RAP1A;RAB8B;RAB29;MRAS;KIF20B;CHD3;BMS1;DNM1;VWA8;MFN2;GNAQ;RAC2;THTPA;NRAS;KRAS;KIF3C;RHOJ;RAB3A;ATL2;GNL2;IRGM;GNAL;GNG3
prerank,anion:anion antiporter activity (GO:0015301),0.4133004982114949,0.9845264985915924,0.4512987012987013,1.0,1.0,2/17,2.41%,SLC4A3;SLC26A9
prerank,proton transmembrane transporter activity (GO:0015078),0.3586809515502585,0.9841300256452832,0.4842681258549932,1.0,1.0,8/39,15.09%,OTOP1;COX5A;SLC4A11;COX15;NNT;COX5B;CLCN5;SLC46A1
prerank,endopeptidase regulator activity (GO:0061135),0.35782629114328346,0.983404943444947,0.48523206751054854,1.0,1.0,4/40,7.19%,SPINK1;APH1B;PSME3;NLRC4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.29439466069928755,0.983209218444716,0.4972972972972973,1.0,1.0,39/188,17.19%,BNC2;GLI1;PBX1;ZBTB20;ETV5;CHD3;SPI1;FOXK1;FOXO3;CREB3L1;GLIS2;HDAC4;CTCF;NCOR1;LIN54;SUV39H1;FOXK2;TBX18;HMGB1;FOXJ1;TFEB;MZF1;EGR1;MEN1;NFE2L2;ARID4A;SOX4;SFPQ;YAP1;ERBB4;RUNX1;KMT2D;FOXC2;PER3;DMTF1;PPARG;MTERF3;PSPC1;TFE3
prerank,protein serine/threonine kinase activity (GO:0004674),0.2802090224824984,0.9804759732573588,0.5297741273100616,1.0,1.0,49/334,11.99%,PLK2;FAM20C;CDK15;PRKCE;CAMK2D;EGFR;MINK1;CLK1;CASK;STK38;MAP3K1;MAPK10;EIF2AK3;PRKCA;BMPR1B;CDKL3;IRAK3;LIMK2;ACVR1C;TRIO;PIK3R4;HIPK1;BRSK1;CDK13;NEK7;BCKDK;CDK7;CLK4;BMP2K;STK38L;MAPK7;SRPK1;MAP3K5;KALRN;DYRK1A;NRBP2;CSNK1G3;GSK3B;RPS6KA3;STK24;STK3;CSNK1A1;MASTL;SRPK2;HTATIP2;TOP1;HUNK;STK35;SGK1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.39472527918290434,-0.9796637610216027,0.4639423076923077,0.8495015988532364,1.0,6/12,16.24%,CDK12;CDK9;CDK6;CDK8;CDK4;CDK19
prerank,snoRNA binding (GO:0030515),0.36402114475926406,0.9792737789305106,0.492603550295858,1.0,1.0,6/30,12.80%,NUFIP1;BMS1;NOP14;SNU13;NOP56;NOP58
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.45543057299946277,0.9787982860850392,0.5017421602787456,1.0,1.0,3/11,10.68%,AKR1B10;RDH14;RDH13
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.39243361722032405,0.9773193101734996,0.481651376146789,1.0,1.0,11/24,22.71%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,cytokine activity (GO:0005125),0.30335002280711804,0.9762102087757301,0.5129650507328072,1.0,1.0,9/131,5.52%,INHBB;IL19;WNT10A;WNT2B;IL1A;WNT16;BMP5;WNT5A;BMP15
prerank,GTPase regulator activity (GO:0030695),0.29133793811257613,0.9746511320957036,0.532620320855615,1.0,1.0,20/212,6.47%,ARHGAP42;SIPA1L1;DLC1;RGS6;RGS14;ARHGAP31;ARHGAP18;ARHGAP32;GRTP1;ARAP1;ARHGAP9;DOCK1;SGSM2;NF1;OPHN1;RACGAP1;GNAQ;GDI1;RAB3GAP2;ARHGAP26
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.1971110984433483,-0.9711176999439517,0.7647058823529411,0.8667540579693614,1.0,118/431,21.53%,PRKAG2;DAPK1;KSR1;RHOBTB1;INSR;MYO1B;MAP3K20;ENPP1;MARK1;LATS2;TGM2;MTHFS;CDC42;SNRK;MFHAS1;TGFBR1;PDXK;ATP7A;AKT3;RPS6KA5;ACVRL1;STK17B;RHOBTB3;SIK1;EEF1A1;MMAA;BLM;TRNT1;SMC4;HSPA8;TWF1;ABCC6;HARS1;GBP3;GBP4;MCM6;RHOC;ABCD4;GCH1;UBA2;TAP2;SYN1;MKNK2;CDK6;AKT1;MYH10;GTPBP10;RAB13;CDKL5;VPS4A;RHOB;RHOH;TUBB2A;RRAGC;TRIB1;OXSR1;GBP6;MKNK1;ACLY;LRRK2;ABCD2;SMARCA5;PMVK;SYN3;ABCA2;MYO18A;SPHK1;ABCE1;PXK;REM1;GBP7;TUBB4B;TUBB6;RRAGD;SEPHS1;MTHFD1L;MTPAP;NOA1;HACL1;ABCG1;ARF5;P2RX7;MVK;GBP2;TUBB4A;PEX6;P2RX4;NOL9;EIF4G1;ANXA6;PEX1;ARL2;RHOT1;TSR1;DHX36;CLP1;RERG;RAB4A;RAB11B;KCNJ8;DIRAS2;PIM1;TUBA1C;RHOF;DAPK3;PFKM;MYH9;RAB32;GNL3;TUBA4A;SYN2;TUBB2B;DYNC1LI1;HRAS;PANK3;ARF3;RAB27A;RAB2A
prerank,methyl-CpG binding (GO:0008327),-0.3185699566065082,-0.9689161105791262,0.47619047619047616,0.8667706487703858,1.0,5/22,13.41%,ZBTB38;CXXC5;WDR77;ZBTB21;LRWD1
prerank,RNA polymerase II complex binding (GO:0000993),0.3642058299271954,0.9670509792031143,0.49572649572649574,1.0,1.0,13/32,22.71%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11
prerank,protein kinase binding (GO:0019901),0.2738022709162893,0.9668616136313067,0.5955510616784631,1.0,1.0,60/479,10.72%,ROR2;CAV1;TRIB2;UTRN;CSPG4;FAM83A;CEACAM1;CNKSR2;CCND3;KCNA5;SLC12A2;GYS1;NELL2;AXIN1;PARD6B;CDH5;STK38;MAP3K1;SPRED1;TRPV4;TJP2;CAV2;FOXO3;RACGAP1;SLC12A4;PRKAG1;SOX9;DNM1;FAM83D;HNRNPA0;IRAK3;RAC2;DACT1;IBTK;PTPRC;TOM1L1;BANK1;ANKRD2;TRIM21;ADAM10;FBXO5;RARA;SRCIN1;MAPK7;MSH2;PTPRJ;PRKAR2A;TEX14;TNIP1;IRGM;PLEK;GSK3B;TOM1L2;TICAM1;MAPKAP1;FERMT2;LAT;ADRA2A;TPR;PRKCSH
prerank,chemokine binding (GO:0019956),0.36854273412539923,0.9662679110048488,0.5101449275362319,1.0,1.0,6/30,24.11%,ACKR3;HMGB1;CCR5;ITGB1;CX3CR1;FGF2
prerank,ribonuclease activity (GO:0004540),0.3301564060697062,0.965922951171553,0.5099866844207723,1.0,1.0,16/56,23.41%,PIWIL2;EXOSC5;N4BP1;DIS3L2;AGO1;EXOSC10;CNOT7;EXOG;ERN1;DICER1;TSNAX;RNASE3;EXOSC7;SMG6;RNASE1;RNASEH1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3834810407171626,0.9649564298430576,0.4992272024729521,1.0,1.0,6/23,9.81%,PHLDA3;SESTD1;SH3PXD2B;KIF16B;PLEKHA4;MAPKAP1
prerank,ribonuclease P RNA binding (GO:0033204),0.46310881459074577,0.964712443466306,0.4973637961335677,1.0,1.0,5/10,23.12%,POP4;POP7;RPP14;RPP21;RPP30
prerank,protein kinase C binding (GO:0005080),-0.2711241629105551,-0.96351900195922,0.49174917491749176,0.8756864042342044,1.0,19/43,23.99%,GRK5;PARD6G;SQSTM1;HDAC7;HDAC9;ADCY4;PDLIM5;DACT2;HSPB1;HINT1;RACK1;PICK1;CAVIN3;NELL1;TOP2A;ADCY6;PRKCB;TOP2B;DSP
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3050268641111464,-0.9629171785504201,0.5250737463126843,0.8711589525350689,1.0,8/26,18.08%,AEBP1;FOLH1;AGBL5;CPXM2;CPD;ACE2;CPA6;VASH1
prerank,sequence-specific mRNA binding (GO:1990825),-0.39767386087128154,-0.9628616719872463,0.49764150943396224,0.8654316015691776,1.0,5/10,27.71%,SSB;LARP6;DHFR;SHFL;RBM24
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.35275165752033233,0.961385681661413,0.52046783625731,1.0,1.0,7/34,15.71%,UBE2L6;UBE2E2;UBE2I;UBE2J2;UBE2D1;UBE2D3;UBE2R2
prerank,ubiquitin protein ligase binding (GO:0031625),-0.20074271763720225,-0.9598023002857966,0.6521739130434783,0.8676795236520014,1.0,60/254,16.67%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;TRIOBP;RBX1;HIF1A;BECN1;TNFRSF1B;SPOP;HSPA8;GABARAPL1;DNAJA1;UBE2N;TRAF6;ARIH1;NEDD8;DBT;UBE2K;SLF2;ACTG1;BCL10;ATP6V0C;NAE1;SLF1;GABARAP;GPR37;VCP;SLC22A18;TRIM28;TPI1;ANKRA2;RPL23;TRIB1;RNF31;UBE2J1;CUL2;PRKAR2B;RAD18;AMBRA1;BAG4;ERLIN2;HERC2;YWHAZ;TRIM37;FZD8;SMC6;ISG15;CBS;LAPTM5;RNF8;NKD2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.35984607263553353,-0.9590017779880949,0.5131578947368421,0.8641194550389617,1.0,4/16,13.24%,SLC26A7;SLC26A2;SLC12A5;SLC1A1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3114037818269453,0.9588414669435242,0.5325953259532595,1.0,1.0,22/83,18.39%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;MINDY3;USP48;USP47;PAN2;USP13;OTUD7B;USP4;USP15;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP37;USP9X;USP53;PSMD14
prerank,amino acid:sodium symporter activity (GO:0005283),0.44007271318706975,0.9587385130348336,0.4905982905982906,1.0,1.0,2/11,5.60%,SLC38A2;SLC6A13
prerank,"DNA binding, bending (GO:0008301)",0.4231827221420839,0.9582106942883731,0.5058823529411764,1.0,1.0,3/14,10.84%,FOXD1;HMGB1;SAP30L
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2910360908638694,-0.9569009282958879,0.5030864197530864,0.8640722878980448,1.0,2/29,1.71%,PRKAG2;PKIG
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.4372268437459064,0.955472886717239,0.5051369863013698,1.0,1.0,1/11,1.47%,ITPR3
prerank,metal ion:proton antiporter activity (GO:0051139),-0.36390539124234816,-0.9553790575202545,0.5279805352798054,0.8624565909724791,1.0,5/13,17.36%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,exoribonuclease activity (GO:0004532),0.4309966299240233,0.9543068876710957,0.5070422535211268,1.0,1.0,3/12,10.02%,EXOSC5;EXOSC10;CNOT7
prerank,outward rectifier potassium channel activity (GO:0015271),-0.39103764968672505,-0.9539708347759531,0.5178571428571429,0.8604216160947883,1.0,2/11,6.18%,KCNK2;KCNT1
prerank,calcium ion binding (GO:0005509),0.27540037357042957,0.9533525403464708,0.5919421487603306,1.0,1.0,29/323,9.25%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;CDH11;ITPR3;SLC25A12;GLCE;CDH5;ACER3;KCNIP4;COLEC11;CDH17;CDH9;TPD52;S100A6;CALR3;NUCB1;S100A7A;ANXA4;LTBP4;RCN1;CDH2;S100B;EML1;PLSCR1;CASQ2;CD320
prerank,low-density lipoprotein particle binding (GO:0030169),0.41364955090668504,0.9527546001916072,0.5161290322580645,1.0,1.0,1/16,0.51%,CDH13
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.44886835426284183,0.952200197921853,0.5244755244755245,1.0,1.0,6/10,28.28%,GLCE;RPE;DSE;GNE;DSEL;RENBP
prerank,tubulin binding (GO:0015631),0.2755317427958243,0.9508239689138018,0.5975103734439834,1.0,1.0,63/295,17.35%,DLEC1;RGS14;HOOK2;KIF2A;GTSE1;SPEF1;KIF20B;TTLL1;TRPV4;RACGAP1;DNM1;FAM83D;AGBL4;SMC3;KIF16B;CAPN6;BRSK1;KIF7;IFT81;PPP1R42;SPAST;KIF3C;DAG1;CKAP5;PAFAH1B1;KIF13A;SGIP1;EML1;CCDC170;IFT74;FNTA;REEP3;TPR;TUBGCP5;S100A9;APC;HDAC6;INO80;MAP4;HOOK3;RAB11FIP5;ARL8B;MAP9;NDE1;MAPRE2;KIF5A;KIF26A;EMD;KIF5B;FAM161A;HTT;POLB;B9D2;TBCE;CRIPT;ARHGEF7;SYBU;AGBL1;EZR;TTLL9;SETD2;CHP1;CEP57
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3563466628137874,0.9485398379143196,0.5201149425287356,1.0,1.0,17/33,25.94%,ZNF326;RPRD1B;LLPH;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;TBP
prerank,UDP-galactosyltransferase activity (GO:0035250),0.45511292405269826,0.9483728229496512,0.5299145299145299,1.0,1.0,2/10,5.97%,B3GALT1;A3GALT2
prerank,ribosomal small subunit binding (GO:0043024),-0.336771303607498,-0.9473998966861918,0.5269922879177378,0.8713992722461131,1.0,8/17,24.28%,NPM1;CPEB2;MTIF2;ABCE1;PIM1;EIF1B;DHX29;ERAL1
prerank,hormone receptor binding (GO:0051427),0.42211726288268137,0.9465770647217522,0.5158069883527454,1.0,1.0,6/14,26.67%,PTHLH;TYK2;JAK1;SOCS2;ADCYAP1;CCK
prerank,carboxypeptidase activity (GO:0004180),0.3577390266704014,0.945856422475307,0.5101449275362319,1.0,1.0,7/35,9.79%,NAALAD2;AGBL4;CPE;CPA2;SCPEP1;BLMH;MINDY2
prerank,histone deacetylase activity (GO:0004407),0.3896752739469192,0.9452505517347994,0.5039494470774092,1.0,1.0,5/19,11.44%,HDAC4;SIRT3;SIRT7;HDAC2;HDAC6
prerank,potassium ion antiporter activity (GO:0022821),-0.3497869012929213,-0.9404495514414832,0.5467980295566502,0.8832621695208528,1.0,5/15,17.36%,SLC24A3;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,bHLH transcription factor binding (GO:0043425),-0.3271376439013273,-0.9370034600484871,0.5502793296089385,0.8868183838975499,1.0,5/19,12.34%,SMAD3;LMO2;MAP3K10;KDM1A;SP1
prerank,phospholipid transfer activity (GO:0120014),-0.3095544909559883,-0.9327620338920345,0.5584795321637427,0.8918138993455239,1.0,6/21,13.94%,PLTP;PITPNB;TNFAIP8L3;C2CD2L;PRELID2;PRELID3A
prerank,adenylate cyclase binding (GO:0008179),0.44160347243317505,0.9327334054917605,0.5256637168141592,1.0,1.0,2/10,5.56%,AKAP12;ADCY5
prerank,phosphatidylinositol binding (GO:0035091),0.2963155116853477,0.9325481820555911,0.5683192261185006,1.0,1.0,7/91,6.77%,PIGU;ITPR2;ITPR3;PITPNC1;SESTD1;ZFYVE16;SNX10
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.27936252622825597,0.9321163491550741,0.6032967032967033,1.0,1.0,29/181,14.33%,MDFIC;PPARGC1A;NFATC1;LDB2;SPI1;HDAC4;DACT1;BHLHE40;NRIP1;TAF4B;ANXA4;ANKRD2;TEAD3;NCOR1;PIAS2;ISL1;DDRGK1;GSK3B;HDAC2;PTPRT;NCOR2;FAF1;NFE2L2;NCOA3;CREBBP;TCERG1;NCOA2;BAZ2A;PSMA6
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.38961621779590005,-0.9318471470352153,0.5422222222222223,0.8886306867475143,1.0,2/10,8.43%,PIK3R3;PIK3C2A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.43087969908885426,0.9312046302636879,0.5638841567291312,1.0,1.0,2/11,5.28%,SLC22A3;SLC25A20
prerank,triglyceride lipase activity (GO:0004806),0.3790275784600764,0.9305011018741107,0.5395348837209303,1.0,1.0,3/20,16.05%,CEL;LIPE;LPL
prerank,miRNA binding (GO:0035198),0.3567304758851155,0.9299870751008203,0.5241477272727273,1.0,1.0,13/30,25.81%,DND1;RBM10;ZNF346;AGO1;PUM2;SPOUT1;PUM1;ELAVL1;ZC3H7B;FMR1;DDX21;PNPT1;AGO2
prerank,metal ion binding (GO:0046872),0.26375635163541383,0.9287489750331303,0.6767676767676768,1.0,1.0,52/477,9.26%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;CDH11;ITPR3;SLC25A12;XYLT2;GLCE;MSH6;CDH5;ACER3;TDG;KCNIP4;COLEC11;CDH17;STK38;CDH9;TPD52;HMGCLL1;S100A6;CALR3;NUCB1;IRAK3;ACVR1C;THTPA;DXO;BRSK1;S100A7A;ANXA4;CERK;ABL2;NLRC4;LTBP4;STK38L;CLYBL;MSH2;DIS3L2;PGM1;RCN1;FOXK2;CDH2;SRPK1;MAP3K5;S100B;EML1;PLSCR1;RPE;CASQ2;CD320;STK3
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27401873513532743,-0.9286474110555004,0.5924657534246576,0.8907112140258023,1.0,8/35,17.84%,POU2F1;FOXP1;NPM1;HDAC1;DRAP1;TBPL1;DR1;TAF1C
prerank,H4 histone acetyltransferase activity (GO:0010485),0.4380986039014894,0.9276041777777324,0.5383304940374787,1.0,1.0,5/10,19.70%,HAT1;MSL3;KAT8;NAA40;NAA60
prerank,protein phosphatase 2A binding (GO:0051721),-0.3161413098089455,-0.9256365943445792,0.5768115942028985,0.8926692459261604,1.0,7/23,14.26%,MFHAS1;FOXO1;CTTNBP2NL;GRIN3A;IGBP1;SPHK1;MAPT
prerank,cytochrome-c oxidase activity (GO:0004129),0.39979955066999096,0.9240841538002095,0.5644654088050315,1.0,1.0,3/15,13.59%,COX5A;COX15;COX5B
prerank,glycerophospholipid flippase activity (GO:0140333),0.4255849790446179,0.9229326122677924,0.5356489945155393,1.0,1.0,4/11,9.87%,ATP8B1;ATP11C;ATP8B2;ATP10B
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.18869060927111264,-0.9218283342182231,0.7346938775510204,0.8965722056823611,1.0,49/269,12.36%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;TRIOBP;RBX1;HIF1A;BECN1;TNFRSF1B;SPOP;HSPA8;GABARAPL1;DNAJA1;UBE2N;TRAF6;ARIH1;NEDD8;DBT;UBE2K;SLF2;ACTG1;BCL10;ATP6V0C;NAE1;SLF1;GABARAP;GPR37;VCP;SLC22A18;TRIM28;TPI1;ANKRA2;RPL23;TRIB1;RNF31;UBE2J1;CUL2;PRKAR2B;RAD18;AMBRA1;BAG4
prerank,omega peptidase activity (GO:0008242),0.29670927535043357,0.9216332331739051,0.5800970873786407,1.0,1.0,23/89,18.39%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;MINDY3;USP48;USP47;PAN2;USP13;OTUD7B;USP4;USP15;USP35;COPS5;GGT1;STAMBPL1;STAMBP;USP45;USP37;USP9X;USP53;PSMD14
prerank,carboxylic acid binding (GO:0031406),-0.26822219426565114,-0.9206118781508358,0.5743944636678201,0.8940925298681478,1.0,11/38,20.26%,UBR1;NOS3;GRIN3A;GRIN2B;GRIN1;GLRA2;MAG;NOS1;GCLC;CASTOR2;CASTOR1
prerank,voltage-gated cation channel activity (GO:0022843),-0.22083508217549477,-0.9203660424172098,0.66,0.8893116997329418,1.0,37/97,35.37%,CACNA2D3;KCNB1;KCNMA1;GRIN3A;CACNB2;GRIN2B;KCNH1;KCNB2;KCNH5;GRIN1;CACNG7;KCNC3;CACHD1;OPRM1;CACNA2D4;TPCN2;KCNA2;KCND1;LRRC38;CACNG4;CACNA1B;KCNH2;KCNQ5;CACNA1D;KCNH8;HCN2;KCNQ1;LRRC55;KCNC4;HVCN1;CACNB3;KCNH4;HCN4;CACNA2D1;CACNA1C;KCNG2;CACNG5
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.419611603609335,0.9202305804485661,0.5512605042016807,1.0,1.0,2/12,9.76%,CYFIP2;EIF4E
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.38875652995084603,-0.9200925649199712,0.562962962962963,0.884541665413647,1.0,5/10,34.76%,CACNB2;CACNA1B;CACNA1D;CACNB3;CACNA1C
prerank,growth factor receptor binding (GO:0070851),0.29578018275514434,0.9191900651784,0.5916359163591636,1.0,1.0,19/95,16.72%,FGF7;GLMN;EFEMP1;FGF1;SRC;FER;NCSTN;PTPRJ;FGF18;PLSCR1;ATXN2;IL6ST;SNX2;ERN1;HBEGF;ERBB4;PIBF1;SNX1;ITGA5
prerank,hyaluronic acid binding (GO:0005540),-0.3916558321032032,-0.9158119016993526,0.5595505617977528,0.889658322339972,1.0,4/10,25.61%,LAYN;C1QBP;LYVE1;CHODL
prerank,phospholipase activator activity (GO:0016004),0.43343567152100465,0.9139608917381054,0.5609756097560976,1.0,1.0,4/10,18.37%,SRC;BTK;STX4;PDPK1
prerank,nuclear export signal receptor activity (GO:0005049),0.4225894303201173,0.9077059997418468,0.5608108108108109,1.0,1.0,6/11,26.02%,CSE1L;RAN;XPO5;XPO4;XPO7;RANBP17
prerank,filamin binding (GO:0031005),0.42170725372209694,0.9076279627399921,0.5481099656357389,1.0,1.0,1/11,1.29%,CEACAM1
prerank,E-box binding (GO:0070888),-0.2685117314065016,-0.9069713002607211,0.6291793313069909,0.9059016997430874,1.0,2/34,4.22%,TCF4;MITF
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.37737535902137087,-0.9068965904935203,0.5835240274599542,0.9007277538868674,1.0,5/10,25.69%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D;DNAJC2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.39128680729717324,0.9057108885432462,0.5700164744645799,1.0,1.0,1/14,1.77%,KCNA5
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.36902525008268605,-0.9056310426169226,0.5720720720720721,0.8982457568894884,1.0,5/11,23.81%,NUDT3;NUDT11;DCP2;NUDT16;NUDT16L1
prerank,kinase inhibitor activity (GO:0019210),0.3363518466454206,0.9052446956456299,0.5674074074074074,1.0,1.0,13/33,23.99%,PARVA;SPRY4;GMFB;MAPK8IP1;HEXIM1;CDKN1C;SOCS1;WARS1;GSKIP;NCK1;TAOK3;YWHAB;PRKRIP1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3506310522305857,0.9026519868409695,0.5694864048338368,1.0,1.0,6/27,11.27%,SLC8B1;SLC12A3;KCNK1;SLC4A11;SLC9A7;SLC9A6
prerank,cyclic nucleotide binding (GO:0030551),-0.31253854169966094,-0.9020953997577208,0.5988700564971752,0.9008730711603199,1.0,5/21,9.13%,RAPGEF2;PDE5A;KCNH1;PDE10A;PDE2A
prerank,nuclear receptor coactivator activity (GO:0030374),0.3100559584061946,0.8995121765544734,0.6050198150594451,1.0,1.0,12/52,18.72%,PPARGC1A;SLC30A9;PSMC3IP;MED13;TMF1;NCOA3;NCOA2;MED12;BRD8;CCDC62;SFR1;TACC1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4076075999876933,0.899169232011748,0.583044982698962,1.0,1.0,6/11,27.93%,STN1;TERF2;RAD50;RPA2;RPA1;TERF2IP
prerank,RNA binding (GO:0003723),0.25297953699327247,0.8981319558355938,0.863,1.0,1.0,316/1321,21.12%,DCN;AHNAK;DHX34;DHX8;PPARGC1A;RPSA;HNRNPC;ASS1;MYBBP1A;CSTF1;CCDC9;CDC42EP4;NUFIP1;FXR2;RBFOX2;HOXB6;DDX27;DND1;QKI;SF3B2;SF3B1;CHD3;BMS1;GIGYF2;PCBP2;DCP1B;RBM8A;RBM10;ADD1;SCG3;CELF1;MRPL37;MRPL43;UBE2I;SRSF4;BUD23;DNM1;CHD2;HNRNPA0;NOL8;PABPC4L;SECISBP2;SAMD4B;SERPINH1;HADHB;CAVIN1;RPUSD2;SNRPF;RBM15B;SON;PABPC4;ZNF326;DXO;TLR7;CDK13;ZNF346;KPNA2;LRRC59;ZC3H15;HNRNPR;PUS7;ZCCHC24;EIF5B;TNS1;TUT1;FASTKD2;SF3B5;C1D;ALDH18A1;PPIE;MRPS28;MRPS35;RARS2;N4BP1;LLPH;DDX17;PRPF3;RDX;ZFR;NCOA5;IGF2BP2;CHERP;FAM120A;ARHGEF1;TOP3B;UTP15;CSTF3;GNL2;NOP14;DDX46;MSI2;RBM22;ILF2;SRPK1;GOLGB1;SIDT2;RBM5;GPATCH8;DARS1;ELAVL2;NAF1;WRAP53;PCDHGA9;AATF;PES1;AGO1;RPL35;LIN28B;DCAF13;SLTM;TCF20;MECP2;SNU13;POP4;PTCD3;MRPL41;FLNB;HMGB1;CELF2;STAU2;EXOSC10;EIF4E;CELF4;FCF1;EIF1AX;EIF1;HDAC2;PTBP3;RPS13;RBM33;HNRNPM;ATXN2;KARS1;PPHLN1;RBM27;RBM26;PRRC2A;TFB2M;DQX1;RTRAF;RRP12;ILF3;TPR;MRPS15;ZYX;KHDRBS2;POP7;DDX43;SRPK2;MRPL3;DBR1;HEXIM1;SREK1;LONP1;RPF1;LUC7L2;UPF3B;MAP4;TOP1;UTP14A;CFAP20;DGCR8;NOP56;UBAP2L;CSDE1;ETF1;SRRM2;SMG7;RBM18;RPP14;PTBP2;ADAT1;ANXA11;TEP1;LTA4H;NOP58;KNOP1;BICC1;STRBP;TAF15;NUCKS1;NSUN5;TCERG1;ALKBH1;DDX6;AIMP1;ZFP36L2;BAZ2A;NOL7;NSRP1;SNRPA1;UBA1;CHCHD1;TEFM;DDX42;TIAL1;BZW1;P4HB;DDX52;DICER1;SFPQ;PSMA6;MEX3A;FXR1;PUM2;FASTKD1;RTN4;TXN;CTNNA1;PPIL4;PPIG;TRA2B;MRPL16;DHX16;RBM38;REXO4;PYM1;PDCD11;SF1;SUGP1;SEC23IP;ATP5F1A;RAN;DHX57;ZCCHC17;SYNCRIP;YWHAG;FLYWCH2;ATP5F1C;CPEB3;MRM1;DHX40;SRRT;SPOUT1;YWHAE;THOC5;TSNAX;PSPC1;MRPL40;MRPL22;ARCN1;PRKRA;UBFD1;EZR;RTF1;SPTBN1;GNL3L;ZCCHC7;XPO5;CWC22;SARS2;NAP1L1;HMGN2;GLRX3;MRPL4;PTCD1;DARS2;NOC3L;SRFBP1;STRAP;TYW5;OAS2;GTPBP1;ZNFX1;FNDC3B;MRPL2;SRSF3;TOE1;PNLDC1;PEG10;MTREX;RPUSD4;SRBD1;CNOT1;YBX3;G3BP1;HARS2;LSM3;XRCC6;GCN1;MBNL2;DHX38;HNRNPD;SEPSECS;DHX9;ZC3H13;DDX56;SAP18;SRSF12;PNISR;CS;SUMO1;LARP4;NCBP3;RPP21;NUDT5;EIF4G2;NME1;USO1;CCT3;JAKMIP1;NUDT21;MKRN1;TDRD9;TRMT1L;RRS1;ENO1;NKAP;ADARB1;KCTD12;GFM1;SRSF11;CCAR2;DDX11;PUM1;SRP68
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.36975449678403155,-0.8964572436007195,0.5892857142857143,0.9087020561658861,1.0,4/10,24.53%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D
prerank,heme binding (GO:0020037),0.3046017225927008,0.8939779957788473,0.6288659793814433,1.0,1.0,9/65,13.28%,STC2;PXDN;CYP2S1;SRC;COX15;SDHD;DGCR8;PGRMC1;CYP2U1
prerank,FAD binding (GO:0071949),0.35160673340340953,0.8939445247305108,0.5864106351550961,1.0,1.0,1/24,0.46%,PRODH
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3947020067399068,0.893044556311391,0.5897009966777409,1.0,1.0,5/14,12.83%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,methyltransferase activity (GO:0008168),0.3126835243625652,0.8899371782649722,0.6042496679946879,1.0,1.0,9/46,13.38%,MRM2;BUD23;SUV39H1;LRTOMT;GAMT;FTSJ1;MGMT;ARMT1;LCMT1
prerank,chemokine receptor binding (GO:0042379),-0.26737576783595796,-0.888830757545495,0.6312056737588653,0.9208536106901353,1.0,24/35,52.06%,CXCL16;CXCL12;CCL13;CCL19;CXCL10;CCL2;CCL25;CCL28;CCRL2;CCL15;CCL5;CCL4;PF4;PPBP;CCL8;CXCL5;CXCL1;CKLF;CCL7;CCL1;CCL3;CCL11;CXCL13;CXCL2
prerank,R-SMAD binding (GO:0070412),-0.3070879730680661,-0.8874405518250406,0.6147959183673469,0.9188330697790925,1.0,2/18,1.64%,SMAD3;SMAD6
prerank,chloride channel regulator activity (GO:0017081),0.394477123098842,0.8870016201177043,0.5960264900662252,1.0,1.0,4/14,18.61%,STX1A;VAMP8;SGK1;CHRNA7
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3558804186027515,0.8860646279786173,0.5987158908507223,1.0,1.0,6/22,11.19%,WDR81;TNFAIP3;UIMC1;MINDY2;OTUD7B;TAB2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.26119451800924653,-0.885576095081242,0.6360424028268551,0.9179791711818587,1.0,10/42,12.48%,PTPN3;PIK3R1;PIK3R3;SHE;CRK;PLCG2;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.37258886394488144,0.8849772905325537,0.571900826446281,1.0,1.0,2/16,5.95%,ALOXE3;BCO1
prerank,poly(A) binding (GO:0008143),-0.3006438651028379,-0.8836123132049947,0.6502890173410405,0.9170461131326497,1.0,5/21,9.67%,RBPMS;RBMS1;RBMS2;PABPC1;RBMS3
prerank,GABA receptor activity (GO:0016917),0.35061609476363087,0.8831832535279582,0.5698234349919743,1.0,1.0,5/21,12.09%,GABBR2;GABRR2;GABRG2;GABRG1;GABRB3
prerank,DNA secondary structure binding (GO:0000217),0.3367624733376259,0.8828622198914414,0.6005788712011577,1.0,1.0,7/31,13.12%,MSH6;KMT2A;LIN54;MSH2;HMGB1;MEN1;GEN1
prerank,lipoprotein particle binding (GO:0071813),0.367157458408974,0.8814313448893514,0.6051779935275081,1.0,1.0,1/20,0.51%,CDH13
prerank,Notch binding (GO:0005112),-0.3006568347947355,-0.8813127657253502,0.6656441717791411,0.9170835714070912,1.0,6/22,9.69%,SNED1;CCN3;GALNT11;JAG2;KCTD10;SNW1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2712654747304728,0.8796277413375615,0.6846846846846847,1.0,1.0,18/134,7.78%,SLC35A1;SLC4A3;SLC25A12;SLC35D3;SFXN2;SLC26A9;SLC38A2;SLC1A7;SLC35B2;SLC27A1;SLC22A3;ABCC1;SLC6A13;SLC2A2;SLC7A2;SLC4A11;SLC35D2;SLC52A1
prerank,mRNA binding (GO:0003729),0.25932139790411374,0.8772735623546002,0.7306468716861082,1.0,1.0,44/249,15.16%,HNRNPC;FXR2;RBFOX2;DND1;QKI;SF3B1;PCBP2;DCP1B;RBM8A;CELF1;SRSF4;HNRNPA0;PABPC4L;SECISBP2;SAMD4B;PABPC4;DXO;HNRNPR;TUT1;PPIE;N4BP1;IGF2BP2;CSTF3;RBM5;ELAVL2;RPL35;CELF2;CELF4;PTBP3;RPS13;HNRNPM;TPR;KHDRBS2;LUC7L2;UPF3B;ETF1;SRRM2;PTBP2;DDX6;NSRP1;FXR1;PUM2;TRA2B;SF1
prerank,iron ion binding (GO:0005506),-0.24145135742762586,-0.8771895708504984,0.700374531835206,0.9211081146240407,1.0,12/48,15.22%,EGLN1;PHF8;FTH1;FTL;AOX1;ETHE1;NFU1;FECH;ABCE1;KDM7A;FXN;ISCA2
prerank,microtubule binding (GO:0008017),0.2561161458798553,0.8766794507751406,0.7044967880085653,1.0,1.0,37/222,13.66%,RGS14;HOOK2;KIF2A;GTSE1;SPEF1;KIF20B;TRPV4;RACGAP1;DNM1;FAM83D;KIF16B;CAPN6;KIF7;SPAST;KIF3C;CKAP5;PAFAH1B1;KIF13A;SGIP1;EML1;CCDC170;FNTA;REEP3;TUBGCP5;S100A9;APC;HDAC6;MAP4;HOOK3;MAP9;CEP290;NDE1;MAPRE2;KIF5A;KIF26A;KIF5B;FAM161A
prerank,cation transmembrane transporter activity (GO:0008324),0.30734722845618245,0.8735721409332113,0.6255088195386703,1.0,1.0,6/48,7.11%,SLC8B1;SFXN2;SLC38A2;SLC29A4;SLC22A3;SLC7A2
prerank,MAP kinase activity (GO:0004707),-0.3347497325401402,-0.8727317026004863,0.6374407582938388,0.9257555743048611,1.0,2/14,6.79%,MAPK4;MAPK12
prerank,organic cation transmembrane transporter activity (GO:0015101),0.38036433002159936,0.8724054751318443,0.6206349206349207,1.0,1.0,3/16,12.60%,SLC29A4;SLC22A3;SLC25A26
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3230939870469151,0.8712218943511318,0.6166180758017493,1.0,1.0,6/31,15.71%,UBE2L6;UBE2E2;UBE2J2;UBE2D1;UBE2D3;UBE2R2
prerank,carboxy-lyase activity (GO:0016831),0.3451380928915188,0.8708822842794361,0.6246200607902735,1.0,1.0,3/23,8.70%,PISD;AZIN2;ACOD1
prerank,kinesin binding (GO:0019894),0.3344867376180154,0.8706336745032782,0.592814371257485,1.0,1.0,13/27,25.71%,RAB29;FAM83D;MAPK8IP1;SPAG9;ARHGEF10;KLC2;SPTBN5;NEK6;PRC1;MAPK8IP3;CLSTN1;KIFAP3;TTBK2
prerank,calcium activated cation channel activity (GO:0005227),-0.3150844388132099,-0.8687445009513901,0.659942363112392,0.929332769068427,1.0,4/17,10.17%,ANO1;KCNMA1;TMEM63B;KCNN2
prerank,mannosyltransferase activity (GO:0000030),-0.2985836579391957,-0.8684718007873662,0.659400544959128,0.9248119969125593,1.0,3/21,4.35%,TMTC2;TMTC1;DPM1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3347868515856881,-0.8683347738690046,0.6388206388206388,0.9200218582031314,1.0,4/12,21.01%,PHF8;KDM1A;KDM7A;KDM4D
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2859014049470734,0.8679445868592004,0.6691919191919192,1.0,1.0,16/74,16.79%,FAM20C;DGKA;HK2;DGKZ;COASY;ADPGK;GALK1;GALK2;IDNK;GK;HYKK;PIK3C3;PANK2;NT5C3A;FGGY;POMK
prerank,mitogen-activated protein kinase binding (GO:0051019),0.33515734146610654,0.8672165815505202,0.6431852986217458,1.0,1.0,6/29,13.32%,NFATC1;MAPK7;PTPRJ;TNIP1;TPR;DUSP8
prerank,voltage-gated calcium channel activity (GO:0005245),-0.257044997428806,-0.8661535396010229,0.6941580756013745,0.9196630957530727,1.0,10/37,25.45%,CACNA2D3;CACNB2;CACNA1G;CACNG7;CACHD1;OPRM1;CACNA2D4;TPCN2;CACNG4;CACNA1B
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.28046620783118636,-0.8649061021616848,0.6308139534883721,0.9173343166868219,1.0,7/26,22.29%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;STYXL1;PTN;ARPP19
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.37885661847881913,0.8621988484348444,0.6408934707903781,1.0,1.0,1/14,1.43%,AK5
prerank,epidermal growth factor receptor binding (GO:0005154),0.3476263976142347,0.8618669288705186,0.6251944012441679,1.0,1.0,8/25,16.38%,EFEMP1;FER;PLSCR1;ATXN2;SNX2;HBEGF;ERBB4;SNX1
prerank,protein phosphatase regulator activity (GO:0019888),-0.23409814632123002,-0.8614531669644425,0.7489878542510121,0.9195190496052008,1.0,19/53,27.96%,PPP2R2B;PPP4R4;CALM1;IGBP1;PPP4R1;CALM3;PPP2R5A;RCAN2;STYXL1;PPP2R5E;PPP4R2;PTN;PPP2R1A;ARPP19;PPP2R5D;DMPK;PPP2R2D;SHOC2;PPP1R16B
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.34981549910850074,-0.8595090153573646,0.640506329113924,0.918904471126767,1.0,4/11,29.91%,KCNJ8;KCNE4;KCNH2;KCNQ1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.34816127028855326,-0.8593798090230562,0.6508313539192399,0.9141374195682562,1.0,2/11,11.13%,CXCL12;YARS1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.3363329581919269,-0.8592400963007845,0.630071599045346,0.9095283397694325,1.0,3/12,15.24%,TRAF6;BABAM2;TRIM37
prerank,ankyrin binding (GO:0030506),0.3588996965109015,0.8591853427333354,0.6204724409448819,1.0,1.0,6/19,20.83%,PTPRC;OBSCN;FLNC;CDH1;SPTBN1;SPTB
prerank,ligand-gated cation channel activity (GO:0099094),0.28225434948707084,0.8571012338526104,0.6754057428214731,1.0,1.0,6/75,6.20%,KCNJ4;KCNJ16;GRIA3;KCNK1;KCNJ13;SHROOM2
prerank,phosphatidic acid binding (GO:0070300),0.35554313146356475,0.8562300739315694,0.6496124031007752,1.0,1.0,6/19,9.81%,PITPNC1;SESTD1;GRAMD1B;PACSIN2;RAPGEF6;MAPKAP1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.336598446243508,0.856108756813058,0.634493670886076,1.0,1.0,8/24,23.82%,AK5;PPIP5K2;PPIP5K1;AK7;ITPKA;NME1;AK9;NME6
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.31934623232037274,-0.8553760021011276,0.6370558375634517,0.9128609736699488,1.0,5/15,12.25%,NDST3;HS3ST1;HS3ST3B1;HS6ST2;HS6ST1
prerank,MHC protein binding (GO:0042287),0.35465610829720906,0.8551103772478427,0.6423017107309487,1.0,1.0,5/20,16.39%,TAPBP;CD81;ABCB9;ATP5F1A;LAG3
prerank,methylation-dependent protein binding (GO:0140034),0.29127559945331327,0.8528169746998657,0.6709844559585493,1.0,1.0,24/57,28.48%,MSH6;CHD8;MORC3;CHD1;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;KDM5A;BPTF;GLYR1;ING1;TDRD3;RRP8;KDM4A;ING3;ING2
prerank,chloride channel inhibitor activity (GO:0019869),0.4012234486978197,0.8490220527694254,0.6281138790035588,1.0,1.0,2/10,11.50%,STX1A;VAMP8
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2886837465336351,0.8489245989920936,0.6938239159001314,1.0,1.0,20/60,19.43%,PPM1A;CTDSPL;PPM1M;RPAP2;PHLPP1;MTMR6;MTMR3;PDP2;CTDSP1;PTEN;CTDSP2;CTDSPL2;PPP4C;CDC14A;CAMK2G;PPP1CA;PP2D1;PPTC7;ILKAP;PPP2CA
prerank,potassium channel activity (GO:0005267),-0.21198446103696794,-0.8484166288464101,0.7988826815642458,0.9226037416841254,1.0,10/89,10.17%,KCNK2;KCNB1;ABCC9;KCNMA1;KCNH1;KCNT1;KCNB2;GRIK2;KCNH5;KCNN2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.24835292342895213,0.8480708955757125,0.7668449197860963,1.0,1.0,28/232,11.21%,NEDD4L;PDZRN3;ZNRF2;PELI2;DTX1;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;PIAS2;SIAH1;ZNRF3;CUL3;DTX4;AMFR;RNF220;CBLB;SIAH3;UBE3D;ANAPC11;RCHY1;NEDD4
prerank,N-acetyltransferase activity (GO:0008080),-0.29664295288332004,-0.8470722331927316,0.6910569105691057,0.9205617285025333,1.0,6/19,22.76%,EP300;SMARCE1;SAT1;KAT2B;NAT8L;NAT2
prerank,phosphatase inhibitor activity (GO:0019212),0.3453753174390879,0.8443811100706321,0.6585760517799353,1.0,1.0,8/20,25.39%,STYX;BOD1L1;ENSA;TESC;LMTK2;PPP1R9B;URI1;PPME1
prerank,voltage-gated sodium channel activity (GO:0005248),0.33152871807349227,0.8438719877837364,0.6615384615384615,1.0,1.0,3/22,10.66%,SCN10A;CACNA1H;SCN2B
prerank,vitamin D receptor binding (GO:0042809),-0.31472312618983744,-0.8393924300420814,0.7037974683544304,0.931203807458698,1.0,7/14,30.51%,MED17;MED24;SNW1;MED14;MED30;TAF11;RXRA
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.38682980738065115,0.8388965855101174,0.6380471380471381,1.0,1.0,7/12,23.73%,CNOT7;PAN2;CNOT8;TOE1;PNLDC1;CNOT1;CNOT2
prerank,poly-purine tract binding (GO:0070717),-0.263604479311043,-0.8374809436942451,0.6987577639751553,0.9303597419781675,1.0,5/27,9.67%,RBPMS;RBMS1;RBMS2;PABPC1;RBMS3
prerank,four-way junction DNA binding (GO:0000400),0.35762824727885817,0.836310808608966,0.6338028169014085,1.0,1.0,5/17,13.12%,MSH6;MSH2;HMGB1;MEN1;GEN1
prerank,amino acid binding (GO:0016597),-0.25708878171309174,-0.8352545704168632,0.6830065359477124,0.9299678629642515,1.0,11/31,20.26%,NOS3;DDAH1;GRIN3A;GRIN2B;GRIN1;GLRA2;NOS1;GCLC;AGXT;CASTOR2;CASTOR1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.30797552818673446,-0.8323288810939791,0.6666666666666666,0.9307946294900608,1.0,8/16,21.14%,SLC13A3;SLC25A30;SLC25A11;SLC38A7;SLC1A1;SLC25A18;SLC1A4;SLC13A5
prerank,voltage-gated potassium channel activity (GO:0005249),0.2717001019859172,0.8319928423411768,0.7292191435768262,1.0,1.0,6/80,5.75%,KCNJ4;KCNA5;KCNJ16;KCNS2;KCNK1;KCNJ13
prerank,CCR chemokine receptor binding (GO:0048020),-0.2644637987244569,-0.8317872632420396,0.7225609756097561,0.9271385022519656,1.0,19/28,51.98%,NES;CCL13;CCL19;CCR2;CCL2;CCL25;CCRL2;CCL15;CCL5;CCL4;CCL8;MSMP;CCL7;DEFB130A;CCL1;CCL3;CCL11;DEFB1;CXCL13
prerank,ubiquitin binding (GO:0043130),0.2744385379811254,0.8315634867033023,0.7126582278481013,1.0,1.0,13/73,12.23%,UBE2L6;NUP62;TOM1L1;TNFAIP3;TSG101;OTUB2;N4BP1;NPLOC4;SHARPIN;USP13;NEDD4;BUB3;FAF1
prerank,thyroid hormone receptor binding (GO:0046966),0.3123563511113154,0.8312050608632287,0.650887573964497,1.0,1.0,9/28,21.57%,NCOR1;MED13;JMJD1C;NCOA3;GTF2H1;MED12;BRD8;TACC1;MED16
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.28329805969227245,0.8263730540389035,0.7333333333333333,1.0,1.0,11/57,14.91%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.31319720851510024,0.8249513304913981,0.685459940652819,1.0,1.0,5/29,13.71%,PGGHG;ACER3;NEU1;ABHD10;ADPRS
prerank,semaphorin receptor binding (GO:0030215),-0.26960725755671616,-0.8245062490388138,0.7581120943952803,0.9363357119228769,1.0,4/23,4.84%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.23359426058543528,-0.8244300159159907,0.7741935483870968,0.9317350734050789,1.0,27/42,38.03%,CCNT2;CNPPD1;CCNT1;CDK5R1;CCNE2;KAT2B;CCNJL;CCNH;CCNY;CCND2;CCNF;CDKN2C;CDKN1B;CCNQ;CCNK;CCND1;CDKN2D;CCNB2;HEXIM2;CCNL1;CDKN2B;CKS2;CCNL2;CDK5R2;CCNE1;INCA1;CCNI
prerank,ubiquitin protein ligase activity (GO:0061630),0.2408599407514172,0.8241344991044264,0.8065887353878852,1.0,1.0,27/228,11.21%,NEDD4L;PDZRN3;ZNRF2;PELI2;DTX1;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;SIAH1;ZNRF3;CUL3;DTX4;AMFR;RNF220;CBLB;SIAH3;UBE3D;ANAPC11;RCHY1;NEDD4
prerank,RNA cap binding (GO:0000339),0.3567793705279451,0.822145329582837,0.656910569105691,1.0,1.0,2/16,9.76%,CYFIP2;EIF4E
prerank,fibroblast growth factor binding (GO:0017134),0.339833122884077,0.8198882923314589,0.6639871382636656,1.0,1.0,1/21,0.71%,FGFR1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.35063542709713674,0.8196333065415431,0.6970684039087948,1.0,1.0,2/18,9.23%,TNFAIP8;RPS6KA3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.30507431789553824,-0.8184662245655805,0.6919191919191919,0.9379981756032038,1.0,6/14,29.80%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,small GTPase binding (GO:0031267),0.2474267884844106,0.8181023182039303,0.7831858407079646,1.0,1.0,40/169,19.21%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;AKAP13;LZTR1;GCC1;RAPGEF4;RAB3GAP2;ABCA1;RAPGEF6;OCRL;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;RANBP2;EXOC5;DMXL2;TRIP11;PDE6D;RAB34;EVI5;CHM;UNC13B;TBC1D20;RTKN;AP3M1;ALS2;XPO5;ARHGDIB;RALBP1;EHD1;SIKE1;ANKFY1;RAF1;DENND10;YBX3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3072831593696153,0.8181009549475103,0.7004341534008683,1.0,1.0,8/34,14.91%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3072831593696153,0.8181009549475103,0.7004341534008683,1.0,1.0,8/34,14.91%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7
prerank,phospholipase inhibitor activity (GO:0004859),-0.34483548454299295,-0.8180819474526215,0.6895734597156398,0.9341335855592884,1.0,7/10,36.68%,ANXA2;ANXA1;ANXA9;ANXA5;APOC1;SNCA;SNCB
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.21043950686423576,-0.8178272044403139,0.8439024390243902,0.9298852795236521,1.0,11/70,14.83%,GXYLT2;MGAT4C;MGAT4A;CSGALNACT1;CSGALNACT2;CHPF2;B4GALT1;B3GALT2;LFNG;MFNG;GCNT1
prerank,CoA hydrolase activity (GO:0016289),0.35362211932454873,0.8174612617711998,0.6892744479495269,1.0,1.0,4/16,12.85%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3641061350138204,0.8164203292701052,0.6549912434325744,1.0,1.0,3/11,13.46%,NTHL1;APEX2;ALKBH1
prerank,transcription cis-regulatory region binding (GO:0000976),0.23525371521826058,0.8162525967417208,0.8752556237218814,1.0,1.0,62/406,16.74%,RORA;BNC2;GLI1;PBX1;ZBTB20;NPAS3;ETV5;CHD3;SPI1;FOXK1;FOXO3;SOX9;ZBTB8A;CREB3L1;GLIS2;KLF10;HDAC4;SATB1;ZFP3;SP3;ZFP90;CTCF;NCOR1;HOXC10;RREB1;RARA;SUV39H1;LHX6;FOXK2;E4F1;ISL1;TBX18;AGO1;HMGB1;FOXJ1;DBP;TFEB;MMP12;LONP1;MZF1;EGR1;MEN1;NFE2L2;PEG3;ARID4A;SOX4;ZFP57;SFPQ;YAP1;ERBB4;FOXF1;NR5A1;RUNX1;KMT2D;FOXC2;E2F1;PER3;GBX1;DMTF1;PPARG;MTERF3;PSPC1
prerank,metalloexopeptidase activity (GO:0008235),0.2857357861087572,0.8146275267296136,0.7264150943396226,1.0,1.0,13/51,17.11%,MMP15;AGBL4;CPE;CPA2;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;MMP14;ZMPSTE24;AGBL1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.36455656951914606,0.8136456395435079,0.688135593220339,1.0,1.0,3/13,9.14%,SOX9;PRKAR2A;GSK3B
prerank,RNA methyltransferase activity (GO:0008173),-0.27842982775464586,-0.8119959671735234,0.7342105263157894,0.9356549044391013,1.0,8/19,24.43%,TGS1;TRMT13;TRMT9B;TRDMT1;FBL;TYW3;METTL8;TRMT12
prerank,cholesterol transfer activity (GO:0120020),0.3530336864848056,0.811860455474149,0.6825657894736842,1.0,1.0,7/16,25.83%,GRAMD1B;ABCA1;STARD5;OSBPL2;NPC2;MTTP;STARD4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3648032520330285,0.8116199467822159,0.6909413854351687,1.0,1.0,6/13,29.14%,GEN1;DICER1;SLX4;DNASE1L1;DNA2;ENDOV
prerank,single-stranded DNA binding (GO:0003697),-0.20035044874658622,-0.8115125273886296,0.8712871287128713,0.9320133759985327,1.0,29/93,24.19%,RAD51B;SAMHD1;TOP3A;BLM;RBMS1;MCM6;PCBP1;SUB1;SPRTN;SSBP1;POLA1;PMS2;MAPT;APTX;SMC6;RAD23A;DHX36;POLR2D;MCMDC2;ERCC4;CRY2;ERCC5;HNRNPA1;TWNK;NEIL3;NABP1;WBP11;CDC45;RAD51
prerank,ribosomal large subunit binding (GO:0043023),-0.3294009279075845,-0.8104624280732308,0.71875,0.9293658959471637,1.0,3/11,12.24%,NPM1;CPEB2;DHX33
prerank,ADP binding (GO:0043531),0.32069585344817725,0.8101638387165209,0.7129629629629629,1.0,1.0,10/25,16.77%,MSH6;PRKAG1;COQ8A;MSH2;MIEF1;LONP1;ABCD1;ERN1;ATP5F1A;PGK1
prerank,potassium:proton antiporter activity (GO:0015386),-0.3366297252685671,-0.8096033317630832,0.7103448275862069,0.9262485649238194,1.0,4/10,17.36%,SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.28229633329539194,0.8091338421989246,0.7198952879581152,1.0,1.0,5/53,8.72%,PRODH;POR;GFER;GCDH;MICAL3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2721965490295852,-0.8088936132201819,0.7386018237082067,0.9228851326819586,1.0,6/22,21.68%,ATP6V0A4;ATP2C1;ATP6V0C;ATP6V1C1;ATP6V1D;ATP6V1E1
prerank,GABA-A receptor activity (GO:0004890),0.3331338531881979,0.8085263603447541,0.6786296900489397,1.0,1.0,4/18,12.09%,GABRR2;GABRG2;GABRG1;GABRB3
prerank,nucleosomal DNA binding (GO:0031492),0.3280419183561867,0.8078369273407998,0.690671031096563,1.0,1.0,3/21,10.01%,HNRNPC;SMARCD2;HDAC2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3036207578360274,0.8046017047999066,0.7021897810218978,1.0,1.0,11/34,21.51%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;TOE1;PNLDC1;CNOT1;EXOSC7
prerank,G protein-coupled receptor activity (GO:0004930),0.23730874938441096,0.8045288289175841,0.8457389428263214,1.0,1.0,18/239,9.82%,HRH1;LPAR1;ADGRG5;ADGRG2;GPR161;MC5R;SSTR1;KISS1R;MRGPRF;P2RY14;OPN1MW;OPN1MW3;GABBR2;GPR135;TSHR;HCRTR2;GPR101;RORB
prerank,thioesterase binding (GO:0031996),0.3694821487246875,0.8031316920935004,0.6843971631205674,1.0,1.0,7/11,23.55%,ARF6;ADRA2A;TRAF4;TRAF5;TRAF3;RAC1;HAUS7
prerank,NF-kappaB binding (GO:0051059),-0.2626598635325814,-0.8020008019712936,0.7640449438202247,0.9304047609106879,1.0,10/24,23.24%,EP300;RNF25;NPM1;HDAC1;BCL10;COMMD7;MTDH;CDK5RAP3;BRMS1;SETD6
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.28779809968504977,0.8010548773681124,0.7237410071942446,1.0,1.0,8/38,11.36%,PHLDA3;SESTD1;LANCL2;SH3PXD2B;KIF16B;PLEKHA4;OBSCN;ZFYVE26
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.2523907528275192,-0.8007786555245426,0.8106508875739645,0.9280954230129395,1.0,7/29,13.24%,SLC13A3;SLC26A7;SLC26A2;SLC25A30;SLC25A11;SLC38A7;SLC1A1
prerank,protein heterodimerization activity (GO:0046982),0.24117722713018996,0.8002603935709112,0.8479212253829321,1.0,1.0,30/178,16.59%,TENM2;NPAS3;FXR2;ADD1;BUD23;SMC3;IRAK3;BHLHE40;ATP1A2;MCL1;GABBR2;PAFAH1B1;USF2;PIK3R2;SUPT4H1;ADRA2A;HEXA;PAFAH1B2;ZHX1;SNX2;EXT1;P4HB;FXR1;FZD9;RAN;ADCY8;ERBB2;SNX1;EXT2;YWHAE
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.23803838257646062,0.7987657849907783,0.8262295081967214,1.0,1.0,20/173,8.73%,FOXP2;ZBTB32;KLF12;ZBTB20;FOXK1;FOXO3;FOXP4;CREB3L1;SATB1;HEYL;BHLHE40;ZFP90;CTCF;TBX2;HIC1;FOXK2;E4F1;MYPOP;TBX18;ZBTB6
prerank,kinase binding (GO:0019900),0.2269920847513464,0.7973352312852886,0.9111111111111111,1.0,1.0,78/434,17.28%,CAV1;UTRN;CSPG4;FAM83A;CEACAM1;CNKSR2;EGFR;CCND3;KCNA5;SLC12A2;GYS1;AXIN1;STX1A;MAP3K1;SPRED1;TRPV4;CAV2;FOXO3;RACGAP1;SLC12A4;PRKAG1;PTPN22;DNM1;SRC;FAM83D;HNRNPA0;IRAK3;RAC2;IBTK;PTPRC;TOM1L1;TRADD;TRIM21;ADAM10;FBXO5;SRCIN1;MSH2;PTPRJ;TEX14;IRGM;GSK3B;TOM1L2;TICAM1;MAPKAP1;DLG3;FERMT2;TAX1BP1;LAT;ADRA2A;WWC1;APC;MVP;FAF1;LRBA;CDC6;SPRED2;PKD1;CIT;HTT;PTPN6;RND2;TTC28;LAPTM4B;MTCP1;PLG;TNNI3;BAD;RELB;TRIM5;AP2A2;UBQLN1;SOCS1;WARS1;RGCC;ARHGEF7;INKA2;USP37;CHP1
prerank,phosphatase activity (GO:0016791),0.26256735534303227,0.7970394495121222,0.7556109725685786,1.0,1.0,14/73,15.15%,DUSP12;PLPP2;ACP6;PLPP3;PTPN22;ACP5;ATP1A2;PTPMT1;PTPRJ;OCRL;ARMT1;DUSP8;PTPRO;PLPPR1
prerank,cAMP binding (GO:0030552),-0.3273035820091401,-0.7947015455222202,0.7304964539007093,0.9340909437899183,1.0,4/11,13.12%,RAPGEF2;PDE10A;PDE2A;PDE4A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3510186968767066,0.7936445824892829,0.6979332273449921,1.0,1.0,4/14,20.41%,CAPN6;CAPN2;CAPN5;CAPN1
prerank,galactosyltransferase activity (GO:0008378),0.37180546826934724,0.7935080555252628,0.697986577181208,1.0,1.0,2/11,5.97%,A4GALT;A3GALT2
prerank,methylated histone binding (GO:0035064),0.2664973154791738,0.792829691343805,0.7635658914728682,1.0,1.0,25/62,28.48%,MSH6;CHD8;MORC3;CHD1;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;KDM5A;TAF1;BPTF;GLYR1;ING1;TDRD3;RRP8;KDM4A;ING3;ING2
prerank,lipase activity (GO:0016298),0.28241482141539664,0.7901120074899669,0.7695590327169275,1.0,1.0,9/43,19.93%,CEL;DDHD1;ABHD12;LIPE;PNPLA8;SEC23IP;LPL;PITPNM3;FAAH
prerank,titin binding (GO:0031432),0.34906753397286433,0.7897972739766644,0.7125850340136054,1.0,1.0,2/13,8.93%,CAMK2D;OBSCN
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3603365897479017,0.7893254023262422,0.6972318339100346,1.0,1.0,1/12,2.62%,CDH5
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.31995807829256406,-0.7888268201511851,0.7345360824742269,0.9394919651095982,1.0,3/11,17.43%,SLC17A5;SLC2A10;SLC2A9
prerank,calcium-activated potassium channel activity (GO:0015269),-0.32043518351082406,-0.7878793774917912,0.7342995169082126,0.936632484287132,1.0,7/11,36.81%,KCNMA1;KCNN2;KCNN3;PKD2L1;KCNN4;KCNN1;KCNMB2
prerank,nuclear import signal receptor activity (GO:0061608),0.34169974145897797,0.7874581308600151,0.7140522875816994,1.0,1.0,2/15,5.73%,KPNA7;KPNA2
prerank,motor activity (GO:0003774),0.26720325694469815,0.7846934833838997,0.783180026281209,1.0,1.0,10/60,13.22%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF5A;KIF26A;KIF5B
prerank,1-phosphatidylinositol binding (GO:0005545),0.34610430505842904,0.7842889124354491,0.7396351575456053,1.0,1.0,3/15,6.77%,SESTD1;ZFYVE16;SNX10
prerank,potassium ion leak channel activity (GO:0022841),0.3385955886646437,0.7840729327284138,0.7219430485762144,1.0,1.0,4/15,14.25%,KCNK1;KCNK5;KCNK4;KCNK10
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.29372974964192633,0.7838772802686162,0.7405797101449275,0.9990744234464903,1.0,9/33,18.52%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;TOE1;PNLDC1
prerank,adenylyltransferase activity (GO:0070566),0.3164935689665738,0.7808269712425976,0.7410714285714286,1.0,1.0,6/21,18.29%,TUT1;COASY;NMNAT3;KARS1;PAPOLG;OAS2
prerank,solute:sodium symporter activity (GO:0015370),-0.24640657124447699,-0.7806567450470725,0.8409785932721713,0.9433187897524977,1.0,2/27,4.76%,SLC4A10;SLC5A6
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3351407491894318,0.7803997042870707,0.7271268057784912,0.9989943764237017,1.0,4/17,12.85%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,single-stranded RNA binding (GO:0003727),0.278843904925858,0.7797561771677357,0.7523056653491436,0.9970904865192881,1.0,17/43,25.81%,TLR7;ZFR;AGO1;EXOSC10;ILF3;LONP1;STRBP;FXR1;DHX9;DDX11;JMJD6;DHX58;IFIH1;FMR1;AQR;CNBP;AGO2
prerank,sulfotransferase activity (GO:0008146),0.28957728382382725,0.7793457108951483,0.7426900584795322,0.9948620775289991,1.0,5/33,11.25%,UST;SULT1A1;CHST7;CHST2;CHST12
prerank,tRNA binding (GO:0000049),-0.2209522266551373,-0.7784316485684739,0.8479087452471483,0.9423923504702938,1.0,20/43,37.98%,SSB;EEF1A1;TRNT1;TRMT9B;EIF2AK4;EIF2A;NSUN2;MRPS27;YRDC;PUS1;XPOT;HSD17B10;NAT10;AARS2;ELP1;TRMT10C;FARS2;CTU1;ELP5;YARS2
prerank,NADPH binding (GO:0070402),-0.30076204932518324,-0.7770353765182106,0.7427884615384616,0.940274421920208,1.0,7/13,34.31%,QDPR;DHFR;MTRR;CRYZ;DUS2;LBR;NDOR1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.35106395305353705,0.7758376326068044,0.7251264755480608,0.9976336376993314,1.0,4/12,18.13%,TUT1;TENT5C;TENT5D;PAPOLG
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.28754274551783093,0.7755646176592353,0.7488921713441654,0.9951025904752104,1.0,13/32,23.35%,EGLN3;TET1;P4HTM;KDM8;ALKBH1;HSPBAP1;PHYH;KDM4B;TYW5;ALKBH4;KDM2A;TMLHE;ALKBH2
prerank,N-acyltransferase activity (GO:0016410),0.28914231819078345,0.7739070518992806,0.7628865979381443,0.9950595236767639,1.0,7/32,15.63%,CERS6;PLAAT5;SAT2;SIRT7;NAT14;NAA10;NMT1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.32195063303676535,0.773811330613698,0.7596153846153846,0.9922860221212728,1.0,1/17,1.43%,AK5
prerank,lysine-acetylated histone binding (GO:0070577),0.3217053614443786,0.7735981611750534,0.744945567651633,0.9868127757606496,1.0,5/20,17.72%,KMT2A;MLLT3;BAZ2A;BRD3;PSME4
prerank,acetylation-dependent protein binding (GO:0140033),0.3217053614443786,0.7735981611750534,0.744945567651633,0.9868127757606496,1.0,5/20,17.72%,KMT2A;MLLT3;BAZ2A;BRD3;PSME4
prerank,ubiquitin-protein transferase activity (GO:0004842),0.22165373520133225,0.7728112612112074,0.9254341164453525,0.985254460438066,1.0,78/346,21.99%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;PELI2;DTX1;UBE2E2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LMO7;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;RNF24;SIAH1;ZNRF3;CUL3;DTX4;FBXO3;AMFR;RNF220;CBLB;SIAH3;UBE3D;ANAPC11;SHARPIN;OBI1;RCHY1;NEDD4;FBXL5;KLHL21;TTC3;FBXO11;RFWD3;FBXO21;RNF185;ANKRD39;UBE2J2;UBE2D1;UBE2D3;ANAPC4;WWP2;FBXW8;UBE2R2;TRIM5;FANCL;DDB2;LTN1;ITCH;FBXL3;CUL4B;RNF7;VPS11;CDC23;RNFT2;RNF180;UBE2W;SEL1L;GID4;RNF14;MKRN1;TRAF5;RNF146;MUL1;RNF157;PRKN;TRAF3;FBXW11;TRAF7;ZNRF1;CUL5;AKTIP
prerank,phosphatidate phosphatase activity (GO:0008195),0.3423549050686444,0.7713095838123734,0.7294938917975567,0.9847858718246717,1.0,2/13,4.08%,PLPP2;PLPP3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.21801248188788153,-0.770229855095644,0.8458904109589042,0.9462163290164811,1.0,5/44,8.55%,MECOM;SETD5;SETD1A;PRDM16;SMYD2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.2903905239797806,-0.7684534268877894,0.8,0.9445810953234506,1.0,12/14,43.27%,QDPR;MTHFR;DHFR;ALDH4A1;PYCR2;PYCR3;AASS;BLVRB;PYCR1;NOXRED1;ALDH1L1;CRYM
prerank,SH3 domain binding (GO:0017124),0.26028233834327325,0.7679496782747893,0.781127129750983,0.9873683399849479,1.0,16/62,21.16%,WIPF1;PTPN22;CNTNAP1;SGIP1;PLSCR1;CBLB;SH3BP2;SOCS7;LANCL1;RUFY2;REPS1;ESPN;PTPN12;AFAP1;PRKN;RAD9A
prerank,GTPase binding (GO:0051020),0.22908476755071852,0.7662520551994065,0.8733624454148472,0.9871375270310028,1.0,45/194,19.21%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;AKAP13;LZTR1;GCC1;RAPGEF4;RAB3GAP2;ABCA1;RAPGEF6;OCRL;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;RANBP2;EXOC5;DMXL2;TRIP11;PDE6D;AIMP1;RAB34;EVI5;RRAGB;CHM;UNC13B;LCP1;TBC1D20;RTKN;AP3M1;ALS2;SPTBN1;BNIP3;XPO5;ARHGDIB;RALBP1;EHD1;SIKE1;ANKFY1;RAF1;DENND10;YBX3
prerank,lipase activator activity (GO:0060229),0.3641299192135584,0.7654593793530797,0.7274305555555556,0.9854159213367352,1.0,3/10,18.37%,SRC;BTK;PDPK1
prerank,P-type ion transporter activity (GO:0015662),-0.29300975744813773,-0.7573594543962533,0.7956730769230769,0.9560980629984931,1.0,8/12,38.48%,ATP7A;ATP2C1;ATP2B3;ATP6V1E1;ATP2B2;ATP7B;ATP2C2;ATP2A1
prerank,water transmembrane transporter activity (GO:0005372),0.34929503670594897,0.7550138114671349,0.7491582491582491,0.9992174219759761,1.0,2/11,13.15%,SLC4A11;AQP1
prerank,acetyltransferase activity (GO:0016407),0.28423518202607834,0.7547184270623665,0.7723342939481268,0.9968297561950811,1.0,9/31,15.20%,KAT6B;ACAT1;SAT2;PAFAH1B2;PAFAH2;NAT14;CREBBP;KAT8;NAA10
prerank,glutamate receptor activity (GO:0008066),-0.26189528534207984,-0.7541921909553848,0.8199445983379502,0.9559279929145369,1.0,3/19,7.75%,GRM3;GRIA2;GRIK2
prerank,ligand-gated ion channel activity (GO:0015276),-0.23210004389860112,-0.7539003850925549,0.8321917808219178,0.9518998989399314,1.0,6/30,10.66%,GRIA2;GRIN3A;GRIN2B;GRIK2;GRIN1;GABRB1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2956871011153828,0.7530871891806061,0.780564263322884,0.9963821153201398,1.0,5/24,13.67%,SESTD1;LANCL2;OBSCN;CERT1;GSDMD
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.25348572654406143,-0.7526623841186112,0.8414985590778098,0.9492992083524032,1.0,13/21,50.61%,GRIK2;P2RX7;P2RX4;CHRNA4;CHRNB2;CHRNB1;P2RX5;P2RX6;CHRNA9;CHRNA5;CHRNA3;P2RX1;CHRNB4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.27184396664853383,-0.7523449083861992,0.828125,0.9411810209210532,1.0,4/16,17.26%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.27184396664853383,-0.7523449083861992,0.828125,0.9411810209210532,1.0,4/16,17.26%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3145466741578312,-0.7523414588317348,0.8032786885245902,0.9369414667727601,1.0,7/10,37.67%,KAT2B;CDKN2C;CDKN1B;CDKN2D;HEXIM2;CDKN2B;INCA1
prerank,ligand-gated channel activity (GO:0022834),-0.23404308511782201,-0.7514221377217256,0.8080808080808081,0.9340258615190862,1.0,6/29,10.66%,GRIA2;GRIN3A;GRIN2B;GRIK2;GRIN1;GABRB1
prerank,ubiquitin-specific protease binding (GO:1990381),0.3119573598478613,0.7502294479322007,0.7662538699690402,0.9979064993807549,1.0,8/19,22.52%,SELENOS;AMFR;PTEN;LCOR;SUMO1;PRKN;DERL1;RHBDD2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2573827984912729,0.7500405738685086,0.8175937904269082,0.9953274635068831,1.0,9/54,11.44%,ACER3;HDAC4;NIT2;NADSYN1;NIT1;DARS1;SIRT7;HDAC2;HDAC6
prerank,cAMP response element binding (GO:0035497),-0.32206437903370655,-0.7493745363237845,0.7709750566893424,0.93275884882567,1.0,3/10,11.94%,CREB5;CREB1;ATF2
prerank,nucleotidyltransferase activity (GO:0016779),-0.26213170686129816,-0.7489964597531993,0.8360655737704918,0.9291418237953468,1.0,6/19,19.72%,PAPSS1;TENT2;TUT7;MTPAP;YRDC;CGAS
prerank,sterol transfer activity (GO:0120015),0.32090161387608923,0.747702279341712,0.7582236842105263,0.9958871909281823,1.0,7/17,25.83%,GRAMD1B;ABCA1;STARD5;OSBPL2;NPC2;MTTP;STARD4
prerank,neuropeptide binding (GO:0042923),0.3113970715193305,0.7469391754206722,0.7584097859327217,0.9942338682428955,1.0,1/18,2.45%,SSTR1
prerank,transferrin receptor binding (GO:1990459),0.35937973339662005,0.7452836468610387,0.7531531531531531,0.9937063953974775,1.0,4/10,21.23%,SNX2;CD81;SNX1;RGMA
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.21973740387015522,-0.7451769386939148,0.8833333333333333,0.9302437068024203,1.0,15/35,29.24%,TRMT13;QRSL1;TRIT1;TRMT9B;TRDMT1;PUS10;DUS3L;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1;DUS2;AARS2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.34862610025115826,0.7450484599047932,0.7628676470588235,0.9912774559152883,1.0,5/11,25.75%,FBXO11;PRMT6;PRMT9;PRMT8;PRMT3
prerank,chloride channel activity (GO:0005254),0.2508481511127188,0.7446619631030867,0.8223086900129701,0.989071991548984,1.0,9/59,12.09%,SLC26A9;ANO6;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,symporter activity (GO:0015293),-0.3151816259914615,-0.7427972754266866,0.8101851851851852,0.9291471989344541,1.0,2/10,12.92%,SLC5A6;MFSD2A
prerank,MAP-kinase scaffold activity (GO:0005078),-0.30335215671044635,-0.7421970894926717,0.7880184331797235,0.9257739784459494,1.0,2/11,7.76%,KSR1;MAP2K2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.30938521182064077,0.7408839756022355,0.7901430842607313,0.9917073320093209,1.0,8/19,23.28%,GRID1;GABRG2;GABRG1;GRIK5;GRIK1;GABRA3;GRIK3;GRID2
prerank,Hsp70 protein binding (GO:0030544),-0.22573820350492618,-0.7394436383419807,0.8571428571428571,0.9253084142390148,1.0,18/31,39.54%,DNAJB2;DNAJA1;GPR37;RPS3;HDAC8;NOD2;DNAJC2;TSC1;MVD;DNAJB1;PPID;FICD;PACRG;SNCA;RNF207;PPEF2;DNAJB14;CYP2E1
prerank,cysteine-type peptidase activity (GO:0008234),0.2418269245776478,0.7379994874592101,0.853416149068323,0.9931526026191494,1.0,15/73,17.69%,USP50;TINAGL1;USP8;USP48;BLMH;USP47;USP13;OTUD7B;CAPN2;USP15;ATG4C;USP35;CTSB;USP37;USP9X
prerank,DNA polymerase binding (GO:0070182),0.31110238957065417,0.7372190184638846,0.7694915254237288,0.9915397970508127,1.0,4/18,14.34%,HMGB1;LONP1;CDK2AP1;POLG2
prerank,endoribonuclease activity (GO:0004521),0.27787908638060627,0.7367580585403524,0.7985611510791367,0.9894815572667063,1.0,6/32,16.69%,PIWIL2;AGO1;EXOG;ERN1;DICER1;TSNAX
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.29932151831061293,-0.7338251895207617,0.803030303030303,0.9285292755540854,1.0,2/12,4.02%,PIK3R1;FRS2
prerank,deoxyribonuclease activity (GO:0004536),-0.27635823135743953,-0.7328722439956813,0.8329355608591885,0.925751060054732,1.0,5/14,20.65%,RPS3;ZRANB3;ERCC4;ERCC5;APLF
prerank,tRNA methyltransferase activity (GO:0008175),0.31118796000131294,0.7327080313763025,0.7960848287112561,0.9926339923846953,1.0,6/16,18.35%,TARBP1;FTSJ1;TRMT5;THUMPD3;METTL2B;METTL2A
prerank,single-stranded DNA helicase activity (GO:0017116),-0.25574886960748766,-0.7264858815960697,0.8350515463917526,0.9296417123889262,1.0,12/19,37.57%,MCM6;POLQ;RFC2;HELQ;RAD51;RFC4;MCM7;MCM5;RFC5;MCM2;CHTF18;PIF1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.30999464694088097,-0.7256236404902268,0.8267898383371824,0.9227267869411435,1.0,3/10,21.71%,DUSP10;DUSP7;DUSP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.30999464694088097,-0.7256236404902268,0.8267898383371824,0.9227267869411435,1.0,3/10,21.71%,DUSP10;DUSP7;DUSP1
prerank,estrogen receptor binding (GO:0030331),0.27766663958510635,0.7248335653181522,0.8301886792452831,1.0,1.0,9/32,19.19%,TAF10;NRIP1;ISL1;DCAF13;STRN;LCOR;CCDC62;TACC1;CNOT1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.3260688239123023,0.7233391512132991,0.7964601769911505,1.0,1.0,5/12,29.43%,BACE2;BACE1;HM13;SPPL3;CTSE
prerank,nuclear localization sequence binding (GO:0008139),0.3014198168124648,0.7221867300383862,0.7976973684210527,0.999163678925135,1.0,3/18,12.55%,KPNA7;KPNA2;NUP153
prerank,5'-3' exonuclease activity (GO:0008409),0.3165490560803519,0.721684080514043,0.8121739130434783,0.9971541960768115,1.0,2/14,10.44%,DXO;EXOG
prerank,MHC class II protein complex binding (GO:0023026),0.3421582421474787,0.7208389769427938,0.7945205479452054,0.9955716371933089,1.0,5/11,22.61%,ANXA11;CD81;YWHAE;MS4A1;PKM
prerank,phosphatidylinositol kinase activity (GO:0052742),0.30544698081413596,0.7192742305573923,0.7740863787375415,0.9948968866374384,1.0,4/15,20.36%,PI4K2B;PIK3C3;PI4K2A;PIK3C2B
prerank,3'-5' exonuclease activity (GO:0008408),0.25664993468884123,0.7153102461808671,0.8468965517241379,0.997522416905273,1.0,14/45,21.51%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;REV3L;REXO4;CNOT8;TOE1;PNLDC1;MRE11;RAD9A;EXOSC7
prerank,MAP kinase kinase activity (GO:0004708),-0.26921525553317094,-0.7121271265209205,0.8534704370179949,0.9340724797826592,1.0,8/15,30.24%,MAP2K2;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;MAP2K1;MAP2K5;MAP2K4
prerank,microtubule minus-end binding (GO:0051011),-0.27712094730425524,-0.7113344713445079,0.8371559633027523,0.9308963483350807,1.0,3/13,10.26%,TUBGCP4;CAMSAP1;MACF1
prerank,microtubule plus-end binding (GO:0051010),-0.2438408078568418,-0.711090373973936,0.8731988472622478,0.9271467274105277,1.0,2/20,3.36%,CLIP1;DST
prerank,nucleotidase activity (GO:0008252),-0.26759521832332145,-0.7102044701179255,0.8406169665809768,0.924306590648168,1.0,5/15,18.99%,BPNT2;NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,rRNA binding (GO:0019843),-0.2027817395288192,-0.7091768463373332,0.9460431654676259,0.921425113183861,1.0,16/42,25.84%,RPLP0;MRPS6;RPL23;RPS3;NGRN;MRPL18;MRPS27;MRPS11;PPAN;RPL5;MTERF4;RPS9;ERAL1;RPS14;FASTKD5;RPF2
prerank,MHC class I protein binding (GO:0042288),0.3182049253479782,0.7073989624548699,0.8035714285714286,1.0,1.0,4/13,22.08%,TAPBP;ABCB9;ATP5F1A;DERL1
prerank,retinoid X receptor binding (GO:0046965),0.32810872826590354,0.706161068440483,0.7972027972027972,1.0,1.0,4/11,18.72%,NRIP1;RARG;PPARG;TACC1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.33442234040402996,0.7046666678853323,0.7927927927927928,1.0,1.0,3/11,10.32%,UBR5;AMFR;ANAPC11
prerank,ferrous iron binding (GO:0008198),-0.23751392971999963,-0.7015772437915015,0.888,0.9255051273569302,1.0,5/21,14.57%,EGLN1;FTH1;FTL;FECH;FXN
prerank,O-methyltransferase activity (GO:0008171),-0.29425644137615287,-0.701289213258888,0.8341121495327103,0.9219046782413666,1.0,2/10,11.79%,COMT;COQ3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.30143781000816205,0.6979911947111209,0.8303130148270181,1.0,1.0,15/15,69.88%,PLA2G4A;PLA2G4C;PLA2G4E;PLA2G4D;PLA2G2F;PLA2G2E;PLA2G1B;PLA2G12A;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4F
prerank,protease binding (GO:0002020),0.22112960481698232,0.697064824901763,0.9342723004694836,1.0,1.0,15/99,13.45%,FAP;SLC2A13;TNFAIP3;FN1;COL3A1;SELENOS;NLRC4;DPP4;AMFR;GSK3B;ATP9A;COL1A1;DVL3;PTEN;ADAMTSL4
prerank,SUMO binding (GO:0032183),0.3110736339221733,0.6962707097318631,0.822742474916388,1.0,1.0,1/13,2.63%,TDG
prerank,phosphoric ester hydrolase activity (GO:0042578),0.24511999504661158,0.6957363849524538,0.8695073235685752,1.0,1.0,10/49,17.34%,DUSP12;ACP6;PTPN22;ATP1A2;PTPRJ;ARMT1;DUSP8;PTPRO;GDPD3;PPP1CA
prerank,hexosyltransferase activity (GO:0016758),0.21806237699136125,0.6925719567697382,0.9306698002350177,1.0,1.0,12/101,11.02%,OGT;B3GALT1;A4GALT;GCNT4;B4GAT1;B3GLCT;GCNT2;PIGB;DPY19L4;POFUT1;ALG9;HEXA
prerank,endodeoxyribonuclease activity (GO:0004520),-0.23707033129493515,-0.6890656697373645,0.8883116883116883,0.9302800840935745,1.0,6/20,21.55%,RPS3;ZRANB3;ERCC4;ERCC5;APLF;DCLRE1C
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.2649409241882941,0.689021223476156,0.8516886930983847,1.0,1.0,9/28,23.28%,GRID1;GABRG2;GABRG1;GRIK5;GRIK1;CHRNA7;GABRA3;GRIK3;GRID2
prerank,guanyl ribonucleotide binding (GO:0032561),0.20393163258742814,0.685298914198633,0.9634801288936627,1.0,1.0,22/196,9.27%,RAP1A;RAB8B;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;PIP4K2B;ARL11;CNGB1;ARHGEF5;CNGA4;NRAS;KRAS;RHOJ;TUBG1;ATL2;GNL2;ARF6;MIEF1;ARL4A
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.24967337463395387,0.6836740302162836,0.8795355587808418,1.0,1.0,10/34,22.59%,SUV39H1;MEN1;ATPSCKMT;SETD2;CAMKMT;KMT5A;ETFBKMT;SETDB1;VCPKMT;EEF2KMT
prerank,ligand-gated calcium channel activity (GO:0099604),0.2797086375991338,0.6819602224441773,0.8415384615384616,1.0,1.0,1/19,1.47%,ITPR3
prerank,acylglycerol lipase activity (GO:0047372),0.3188321339619047,0.6772964479968686,0.8351063829787234,1.0,1.0,3/11,19.93%,ABHD12;LIPE;FAAH
prerank,pentosyltransferase activity (GO:0016763),0.2535299118374898,0.6771532842045257,0.875,1.0,1.0,6/36,12.98%,UPP2;SIRT3;PPAT;PARP11;PARP6;PARP8
prerank,hexose transmembrane transporter activity (GO:0015149),0.3059484495908814,0.6755941245607597,0.8363636363636363,1.0,1.0,3/12,19.34%,SLC2A2;SLC5A3;MFSD4A
prerank,nuclease activity (GO:0004518),0.2353827092799739,0.6720551887744024,0.8865153538050734,1.0,1.0,18/52,26.85%,NTHL1;N4BP1;DIS3L2;DFFB;PLSCR1;EXOG;REXO1;REXO4;RNASE3;MRE11;NME1;RNASE1;N4BP2;RNASEH1;DNASE1L1;OGG1;AEN;ANG
prerank,retinoic acid receptor binding (GO:0042974),0.2804970185112903,0.6697800054212716,0.8589951377633711,1.0,1.0,5/17,19.19%,NRIP1;RARG;PPARG;TACC1;CNOT1
prerank,U6 snRNA binding (GO:0017070),0.28841427618816146,0.667039941320582,0.867003367003367,1.0,1.0,2/14,7.84%,TUT1;RBM22
prerank,glucuronosyltransferase activity (GO:0015020),0.2785893876080219,0.6651761028626673,0.87893864013267,1.0,1.0,5/19,25.24%,B4GAT1;EXT1;EXT2;B3GAT2;CHPF
prerank,GTP binding (GO:0005525),0.19958231307777935,0.6640661176781345,0.9736263736263736,1.0,1.0,38/172,20.71%,RAP1A;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;PIP4K2B;ARL11;ARHGEF5;NRAS;KRAS;RHOJ;TUBG1;ATL2;GNL2;ARF6;ARL4A;ARL8B;TUBG2;RND2;RRAGB;LSG1;ARL5A;MTG2;RAN;RAB21;GEM;RAB27B;RHOA;RABL3;TUBD1;RAB5A;RAB39A;RALA;NME1;RND3;GLUD1
prerank,glucose transmembrane transporter activity (GO:0005355),0.28155171875484664,0.662019510337649,0.8535433070866142,1.0,1.0,4/17,19.34%,SLC2A2;SLC5A3;SLC5A11;MFSD4A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.28736472238265615,0.6593932218952884,0.8621794871794872,1.0,1.0,1/15,3.14%,KMT2A
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.21994650065379992,-0.6569521329233619,0.9080459770114943,0.95494313146535,1.0,7/22,20.25%,CPEB2;RBMS3;ZC3H12A;CPSF1;ZFP36;DHX36;CPEB1
prerank,exonuclease activity (GO:0004527),0.2311078188152473,0.656610374372754,0.9075391180654339,1.0,1.0,10/46,14.97%,EXOSC5;DXO;REXO2;EXOSC10;CNOT7;APEX2;EXOG;REXO1;REV3L;REXO4
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.16212513831928024,-0.6549081285841849,0.9947643979057592,0.9527239795448013,1.0,13/85,15.51%,ENPP2;NDST3;LYPLA1;NOTUM;ASPG;ABHD5;ABHD3;PNPLA6;ABHD2;LIPA;LYPLAL1;PGLS;CA2
prerank,nuclear receptor binding (GO:0016922),0.20552491212132648,0.6527421892774857,0.960233918128655,1.0,1.0,19/111,15.44%,PPARGC1A;TAF10;NRIP1;NCOR1;ISL1;MED13;DCAF13;TMF1;NCOR2;STRN;JMJD1C;NCOA3;GTF2H1;NCOA2;BAZ2A;MED12;LCOR;BRD8;CCDC62
prerank,double-stranded RNA binding (GO:0003725),0.2148646030484306,0.6496750845727463,0.9438902743142145,1.0,1.0,25/70,25.81%,TLR7;ZNF346;ZFR;ILF2;SIDT2;AGO1;STAU2;ILF3;DGCR8;STRBP;DICER1;FXR1;PRKRA;OAS2;DHX9;ADARB1;ELAVL1;DHX58;ACTN1;IFIH1;PRKRIP1;FMR1;TUBA1B;DHX30;AGO2
prerank,ATPase regulator activity (GO:0060590),0.23905272280345063,0.6491238334777162,0.9245283018867925,1.0,1.0,10/38,20.04%,HSPH1;SIL1;BAG3;ATP1B3;AHSA1;BAG2;DNAJC24;DNAJB4;DNAJC19;GRPEL2
prerank,damaged DNA binding (GO:0003684),0.23334202611958998,0.6490243203145268,0.9173669467787114,1.0,1.0,8/44,17.22%,TDG;NTHL1;NBN;HMGB1;ERCC1;CREBBP;DDB2;CUL4B
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2288211657128793,0.6460378980026452,0.909217877094972,1.0,1.0,11/40,19.19%,TARBP1;SUV39H1;LRTOMT;GAMT;METTL9;ARMT1;LCMT1;THUMPD3;METTL2B;METTL2A;ICMT
prerank,phosphatidylglycerol binding (GO:1901611),0.28386074532709427,0.6425874809355965,0.8571428571428571,1.0,1.0,3/13,13.67%,PITPNC1;MME;GSDMD
prerank,protein kinase regulator activity (GO:0019887),0.20337277055513614,0.6403698841752766,0.9637681159420289,1.0,1.0,12/95,12.23%,PARVA;CCND3;PRKAG1;SPRY4;GMFB;CCNG1;PRKAR2A;CCNJ;MAPK8IP1;HEXIM1;APC;FAF1
prerank,endonuclease activity (GO:0004519),0.2277038720282713,0.638991205383347,0.9195088676671214,1.0,1.0,8/49,16.69%,PIWIL2;NTHL1;AGO1;EXOG;ERN1;DICER1;REXO4;TSNAX
prerank,transmitter-gated ion channel activity (GO:0022824),0.24249103040565484,0.632206777452564,0.9133034379671151,1.0,1.0,11/29,23.78%,GRID1;GABRG2;GABRG1;GABRB3;GRIK5;GRIK1;GLRA3;GABRA3;GRIK3;GRID2;GRIA4
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3045161628402916,0.6314113286426863,0.8606965174129353,1.0,1.0,1/10,5.60%,SLC6A13
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.25259153476961604,-0.6306817616252743,0.9038461538461539,0.9659611549548698,1.0,1/12,1.24%,ENTPD1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.256233067859778,0.627040569586719,0.9102362204724409,1.0,1.0,3/22,13.32%,DUSP12;MTMR3;DUSP8
prerank,NAD+ binding (GO:0070403),0.2824720650766447,0.6258932239194741,0.8708551483420593,1.0,1.0,5/12,23.45%,SIRT3;HPGD;GLUD1;SIRT2;UXS1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.2809851145550029,0.6236508374952358,0.8770343580470162,1.0,1.0,3/12,12.09%,GABRG2;GABRG1;GABRB3
prerank,5'-nucleotidase activity (GO:0008253),-0.2415157678271305,-0.6233969729759604,0.9128329297820823,0.9666430536617638,1.0,4/13,18.99%,NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,muscle alpha-actinin binding (GO:0051371),0.2704049949660292,0.6189893654762785,0.9186991869918699,1.0,1.0,1/15,2.25%,PDLIM4
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2851952789010689,0.6118006155708734,0.909556313993174,1.0,1.0,4/11,19.60%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,translation initiation factor activity (GO:0003743),0.22150310979125554,0.6034757269161178,0.9537166900420757,1.0,1.0,5/36,11.56%,EIF2B3;EIF5B;EIF4E;EIF1;EIF2B4
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.23387303266227433,0.6026748723689637,0.9422222222222222,1.0,1.0,10/28,25.81%,POP4;POP7;DBR1;RPP14;DICER1;RPP21;RPP30;RNASEH1;PRORP;AGO2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.27106961488139697,0.5916582757603707,0.9084745762711864,1.0,1.0,4/12,19.60%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,aspartic-type peptidase activity (GO:0070001),0.2780997056928659,0.5901930780864619,0.9128113879003559,1.0,1.0,2/10,16.71%,BACE2;BACE1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2742670795696682,0.5901891799759282,0.9168081494057725,1.0,1.0,6/11,28.69%,NAA10;NAA40;NAA60;NAA30;NAA20;NAA80
prerank,histone deacetylase binding (GO:0042826),0.19121770399261542,0.5891171787208614,0.9826732673267327,1.0,1.0,24/88,22.66%,SPI1;HDAC4;DACT1;KPNA2;NCOR1;HIC1;HDAC2;NCOR2;HDAC6;CAMTA2;SFPQ;LCOR;YWHAE;GMNN;MTA3;HDAC3;RBBP4;NUDT21;PRKN;RAD9A;MAPK8;BRMS1L;SIRT2;YWHAB
prerank,CARD domain binding (GO:0050700),0.25260895820560547,0.5831012658951481,0.9196428571428571,1.0,1.0,2/14,8.76%,CARD10;IRGM
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.23250485602554158,0.5802732018592016,0.953125,1.0,1.0,8/21,24.76%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;REV1;PRIMPOL
prerank,leucine zipper domain binding (GO:0043522),-0.2461243450104847,-0.5760484398324635,0.9411764705882353,0.9866105606008457,1.0,3/10,19.23%,PAWR;ATF4;DAPK3
prerank,snRNA binding (GO:0017069),0.20268787827476276,0.5720925535631965,0.9736111111111111,1.0,1.0,6/42,13.93%,RNPC3;TUT1;RBM22;SNU13;HEXIM1;SNRPA1
prerank,Toll-like receptor binding (GO:0035325),0.26049839934718466,0.5711988402211297,0.9365079365079365,1.0,1.0,11/11,73.97%,S100A9;TOLLIP;TIRAP;S100A8;TLR2;TLR1;CD36;DAB2IP;TLR6;UNC93B1;MYD88
prerank,DNA polymerase activity (GO:0034061),0.22704852528783045,0.5690134918605144,0.9625,1.0,1.0,8/22,24.76%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;REV1;PRIMPOL
prerank,Hsp90 protein binding (GO:0051879),0.2117590423732989,0.5609261857274959,0.9593023255813954,1.0,1.0,6/33,16.18%,SLC12A2;NPAS2;HDAC6;AHSA1;ERN1;CHORDC1
prerank,histone methyltransferase binding (GO:1990226),-0.2262661130806763,-0.5598702375092522,0.9641148325358851,0.9890008856828828,1.0,1/11,4.32%,LCORL
prerank,ATP hydrolysis activity (GO:0140603),0.19874290324823612,0.5507227992603024,0.9746478873239437,1.0,1.0,3/41,4.45%,KIF20B;CHD3;VWA8
prerank,ligand-gated anion channel activity (GO:0099095),0.23214233577073953,0.5488328983792767,0.9353146853146853,1.0,1.0,6/17,22.81%,GABRG2;GABRG1;GABRB3;GLRA3;GABRA3;GLRB
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.25353085179838064,0.5421222637025295,0.9543918918918919,1.0,1.0,11/11,74.66%,CHRNA7;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNA9;CHRNB1;CHRNB2;CHRNA4
prerank,cardiolipin binding (GO:1901612),0.24951220359087753,0.5399448998767216,0.9571917808219178,1.0,1.0,4/10,23.77%,MME;GSDMD;STOML2;UQCC3
prerank,disordered domain specific binding (GO:0097718),0.21443196531090725,0.5388378948071316,0.9608433734939759,1.0,1.0,3/23,12.33%,FN1;DFFB;NCOA3
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.20220476850409885,-0.5378492808286424,0.9765625,0.9919701565109261,1.0,8/15,39.09%,P2RX7;P2RX4;GPR34;P2RY12;P2RY1;PTAFR;P2RX5;P2RX6
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.25134423465485684,0.5323511175233839,0.9545454545454546,1.0,1.0,2/10,11.42%,GABRG2;GABRG1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.23620189752900356,0.5280976725756984,0.9508196721311475,1.0,1.0,7/13,27.75%,GABRG2;GABRG1;GLRA3;GABRA3;GLRB;GABRG3;GABRA1
prerank,translation elongation factor activity (GO:0003746),-0.1971641894807243,-0.5188195165219607,0.9757281553398058,0.993115077737347,1.0,7/14,31.98%,EEF1A1;EEF1B2;EEF2;TUFM;EIF5A;EIF5AL1;EEF1A2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.19489967990769597,0.5173456919141954,0.9884892086330935,1.0,1.0,1/32,1.77%,KCNA5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.21829194861311826,0.5151382906169072,0.9667221297836939,1.0,1.0,8/17,25.77%,DECR2;DHCR24;DECR1;BLVRA;PECR;MECR;PTGR1;PTGR2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.20066948894233078,0.5148183373569972,0.9798761609907121,1.0,1.0,2/26,7.20%,B3GALT1;EXTL2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.23467369183583964,0.5134746176831059,0.959114139693356,1.0,1.0,2/12,14.68%,DHRS4;AIFM2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.20207223475543173,0.506207639158222,0.978328173374613,1.0,1.0,4/25,12.98%,SIRT3;PARP11;PARP6;PARP8
prerank,N-methyltransferase activity (GO:0008170),0.20220234699739878,0.5035299982617112,0.9744816586921851,0.9998894116903323,1.0,6/20,22.54%,TFB2M;METTL5;TRMT1L;TRMO;TRMT1;TFB1M
prerank,DNA replication origin binding (GO:0003688),0.20119452288261408,0.5004631365746784,0.9825673534072901,0.9983934629260676,1.0,8/23,24.93%,ORC5;ORC3;CDC6;ORC1;DHX9;DDX11;MCM4;ORC4
prerank,signal sequence binding (GO:0005048),0.18373722481301138,0.49756059343693043,0.9898107714701602,0.9968454628221034,1.0,2/35,5.73%,KPNA7;KPNA2
prerank,neuropeptide hormone activity (GO:0005184),0.20402010050251254,0.4965900640129506,0.9753086419753086,0.9947969568528504,1.0,22/22,79.63%,HCRT;AGRP;ADCYAP1;NPFF;PPY;CCK;NPY;OXT;QRFP;CORT;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;GRP;SPX;PENK
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.18853667849130878,0.491853334173407,0.9850523168908819,0.9936512607408535,1.0,2/30,9.23%,TNFAIP8;RPS6KA3
prerank,telomeric DNA binding (GO:0042162),0.1801491227542283,0.48814957239927687,0.986822840409956,0.9921963562603032,1.0,11/32,27.93%,STN1;UPF2;SMG7;TERF2;XRCC6;HNRNPD;SMG6;RAD50;SMG5;RPA1;TERF2IP
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.1799100405070001,-0.48223371562356854,0.989501312335958,0.9963808411738425,1.0,8/15,48.56%,CMKLR1;CCR2;GPR17;CCRL2;CCR9;CCR1;ACKR4;CCR6
prerank,lysine N-methyltransferase activity (GO:0016278),0.1894552942543002,0.4686069107580767,0.9840255591054313,0.9939569568310228,1.0,6/20,22.59%,ATPSCKMT;SETD2;KMT5A;ETFBKMT;VCPKMT;EEF2KMT
prerank,peptide N-acetyltransferase activity (GO:0034212),0.21484003946171637,0.4544885407427673,0.982363315696649,0.9940493906023753,1.0,5/10,28.69%,NAA10;NAA60;NAA30;NAA20;NAA80
prerank,histone methyltransferase activity (GO:0042054),-0.13051640231486883,-0.4298175982130562,1.0,0.9977770426728415,1.0,15/32,40.25%,SMYD2;PRMT7;SUZ12;EED;FBL;EHMT2;SMYD3;TTLL12;KMT2E;NTMT1;SETD7;N6AMT1;EHMT1;PRMT1;CARM1
prerank,phospholipase A2 activity (GO:0004623),0.15738472916492718,0.4058024202628209,1.0,0.9971977814872651,1.0,4/26,22.60%,PLAAT5;PNPLA8;PRDX6;PLA2G4A
